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Genetically programmed cell death (PCD) mechanisms, including apoptosis, are important
for the survival of metazoans since it allows, among things, the removal of damaged cells
that interfere with normal function. Cell death due to PCD is observed in normal processes
such as aging and in a number of pathophysiologies including hypoxia (common causes
of heart attacks and strokes) and subsequent tissue reperfusion. Conversely, the loss of
normal apoptotic responses is associated with the development of tumors. So far, lim-
ited success in preventing unwanted PCD has been reported with current therapeutic
approaches despite the fact that inhibitors of key apoptotic inducers such as caspases
have been developed. Alternative approaches have focused on mimicking anti-apoptotic
processes observed in cells displaying increased resistance to apoptotic stimuli. Hormesis
and pre-conditioning are commonly observed cellular strategies where sub-lethal levels
of pro-apoptotic stimuli lead to increased resistance to higher or lethal levels of stress.
Increased expression of anti-apoptotic sequences is a common mechanism mediating
these protective effects. The relevance of the latter observation is exempliﬁed by the
observation that transgenic mice overexpressing anti-apoptotic genes show signiﬁcant
reductionsintissuedamagefollowingischemia.Thusstrategiesaimedatincreasingthelev-
els of anti-apoptotic proteins, using gene therapy or cell penetrating recombinant proteins
are being evaluated as novel therapeutics to decrease cell death following acute periods
of cell death inducing stress. In spite of its functional and therapeutic importance, more is
known regarding the processes involved in apoptosis than anti-apoptosis.The genetically
tractable yeast Saccharomyces cerevisiae has emerged as an exceptional model to study
multiple aspects of PCD including the mitochondrial mediated apoptosis observed in meta-
zoans.To increase our knowledge of the process of anti-apoptosis, we screened a human
heart cDNA expression library in yeast cells undergoing PCD due to the conditional expres-
sion of a mammalian pro-apoptotic Bax cDNA. Analysis of the multiple Bax suppressors
identiﬁed revealed several previously known as well as a large number of clones represent-
ing potential novel anti-apoptotic sequences.The focus of this review is to report on recent
achievements in the use of humanized yeast in genetic screens to identify novel stress-
induced PCD suppressors, supporting the use of yeast as a unicellular model organism to
elucidate anti-apoptotic and cell survival mechanisms.
Keywords:heartfailure,apoptosis,programmedcelldeath,anti-apoptoticgenes,Bax,geneticscreen,pre-condition,
hormesis
INTRODUCTION
Getting rid of unwanted or potentially damaging cells is critical
forthenormalfunctioningof metazoans(Wyllie,2010;Porttetal.,
2011; Ulukaya et al., 2011). More recently, genetically encoded
mechanisms have been discovered to be of equal importance in
regulating cell death and cell survival in all eukaryotes includ-
ing single cell microbes such as the yeast Saccharomyces cere-
visiae (Carmona-Gutierrez and Madeo, 2009; Shemarova, 2010;
Kaczanowskietal.,2011).Thishasledtodramaticchangesinhow
programmed cell death (PCD) is perceived and it has opened up
a number of important avenues of research that allows genetic
approaches to the study of death inducing and cell survival strate-
gies. It has long been established that the functional expression
of human genes in yeast has facilitated the study of individual
members of complex gene family in an isolated but functional cell
system. The use of humanized yeast cells for the study of apop-
tosis started many years ago when key regulators of mammalian
apoptosiswerefoundtoretaintheirpro-andanti-apoptoticfunc-
tions when expressed in yeast (Manon et al., 1997; Ligr et al.,
1998; Lisa-Santamaria et al., 2009). Today humanized yeast cells
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are commonly used as a means of identifying and characteriz-
ing novel apoptotic regulators and processes (Greenwood and
Ludovico, 2010; Silva et al., 2011a). As a prelude to a detailed
discussion of the use of humanized yeast, it is necessary to intro-
duce a few related topics. A general discussion will begin with the
fact that although a multitude of specialized sub-forms have been
describedtherearethreemaintypesof PCDsthatreceivethemost
attention (Hotchkiss et al.,2009; Orrenius et al.,2011; Portt et al.,
2011; Galluzzi et al.,2012b).
TypeIPCDorapoptosishaslongbeenrecognizedascontaining
two distinct types called the extrinsic and intrinsic forms (Kroe-
mer et al., 2009; Wyllie, 2010). The extrinsic form is largely due
to the activation of cell surface death receptors such as TNFα and
is more studied in the context of the immune cells. The intrinsic
form is centered on the mitochondria and is activated by a vari-
ety of stresses including a number of chemicals (pesticides,cancer
therapeutics), physical agents (high osmolarity, change in tem-
perature or pH), and intracellular stresses such as DNA damage
and accumulation of misfolded proteins especially in the endo-
plasmic reticulum (ER; Carmona-Gutierrez et al., 2010; Orrenius
et al., 2011). These stresses lead to the activation of intracellular
pathways and processes that cause alterations in mitochondrial
membrane permeability and the release of pro-apoptogenic fac-
tors including cytochrome c, AIF, and Endo G. The effects of
cytochrome c are mediated by its ability to form an active apop-
tosome complex with the Apoptosis Protease Activating Factor 1
(APAF-1)thatservestoactivateprocaspase9.Thisinturnleadsto
cleavage mediated activation of executioner caspases such as cas-
pase3.Therearenumberofotherinterrelatedpathwaysassociated
with the intrinsic pathway which involves a large variety of pro-
apoptotic proteins. Many of these stresses can be shown to induce
cell death when overexpressed and to reduce stress mediated cell
death when their genes are knocked out or down regulated by
siRNAbasedstrategies.Thereaderisreferredtoanumberofrecent
reviews for more detailed accounts of these processes (Orrenius
et al.,2011; Shamas-Din et al.,2011; Ulukaya et al.,2011; Galluzzi
et al.,2012b).
AUTOPHAGY
Type II PCD or autophagic cell death may not be more complex,
but at the moment, it certainly is a lot more confusing (Den-
ton et al., 2012; Galluzzi et al., 2012a,b; Shen et al., 2012). This is
becauseautophagy(Greek,self-eating)isinitself acellularprocess
that serves to protect the cell from stress (Moreau et al., 2009).
Although there are multiple different forms,the most understood
form is called macro-autophagy (He and Klionsky, 2009). Here
the autophagic machinery is activated in response to nutritional
stress where it earmarks cellular constituents that are expendable
(i.e., material required for growth). These are then broken down
and serve as building blocks for the synthesis of molecules and
the expression of genes that can serve to prevent premature cell
death. The autophagic machinery gets activated in the absence of
nutrient by a well studied complex process involving a variety of
regulatory proteins including TOR (Loewith and Hall,2011). The
ability to genetically identify a large number of autophagic (ATG)
genes in yeast was instrumental in developing our understanding
of autophagy(HeandKlionsky,2009).Theavailabilityof mutants
lacking ATG genes due to knock out or knock down have shown
that the process of autophagy is critical for cellular survival in
response to a variety of stresses including amino acid and glucose
starvationaswellchemicalinducersof apoptosis(Panetal.,2009).
Otherformsofautophagythatcarryoutspecializedfunctionssuch
as the selective removal of certain cellular constituents including
the speciﬁc removal of damaged mitochondria by mitophagy may
alsobecriticalforcellularsurvivalundersomeconditions(Kissova
and Camougrand, 2010). On the other hand low level removal of
damaged cellular material by constitutive autophagy is thought to
have housekeeping functions that are required to maintain proper
order in a cell (Gottlieb et al.,2009; Marino et al.,2011).
In contrast to the large body of knowledge about the protective
effects and processes associated with the pro-survival functions
of autophagy (see also below) even the bare essential framework
for autophagic cell death is lacking (Chen and Klionsky, 2011).
Autophagiccelldeathwasoriginallydeﬁnedasaformof celldeath
thatisassociatedwithautophagosomesthatislikelynon-apoptotic
(caspase, Bax independent; Marino et al., 2011; Meschini et al.,
2011). Autophagosomes are intracellular vesicles that are the site
of the autophagic cargo destined for degradation that consist of
the membrane engulfed cargo fused to lysosomes. The connec-
tion between autophagy and autophagic cell death still remains
obscure. In fact there is quite a strong and growing conviction
by many that autophagic cell death would be better labeled as
cell death associated with autophagosomes (Denton et al., 2012;
Shen et al., 2012). Thus autophagy is often labeled as an “inno-
cent bystander”in the process of an ongoing death (Rami, 2009).
It is argued that conditions that serve to initiate cell death, will
lead to stress mediated activation of autophagy as a sort of cel-
lular defense mechanism (Schleicher et al., 2010). The increased
autophagy is thus a way for the cell to try and mitigate and resist
undergoing inappropriate cell death (Meschini et al., 2011). The
up-regulation of such cellular survival processes have been iden-
tiﬁed in response to numerous stresses (Fulda et al., 2010; Portt
etal.,2011).Theinabilitytopreventcelldeathsthatarethoughtto
beoccurringbyautophagy,byinhibitingtheautophagicprocessis
regardedasstrongevidencethatautophagiccelldeathislikelyover
diagnosed (Galluzzi et al.,2012b; Shen et al.,2012). Strong guide-
lines or recommendations by a number of leaders in the ﬁeld have
been proposed to try and demystify the process (Galluzzi et al.,
2012b). It nevertheless remains technically challenging to identify
cell death by autophagy. This is partially due to the fact that small
chemicalinhibitorsofautophagyusedarenon-speciﬁc.Theability
to develop speciﬁc chemical inhibitors or genes encoding negative
regulators, as was recently done for necrosis, would be required
to clearly identify and characterize autophagic death (Wu et al.,
2012).
Nevertheless, autophagic cell death has been acknowledged to
exist,evenbythemostardentanti-autophagicdeathcrowd,under
certain circumstances, and in some organisms (Shen et al., 2012).
For example apoptotic inducing stimuli leads to autophagic cell
deathinmouseembryonicﬁbroblasts(MEFs)cellsthatareunable
to carry out apoptosis due to knock outs of both pro-apoptotic
Bcl-2 family members,Bax and Bak (Shimizu et al.,2004). Others
have argued that autophagic cell death may simply be a sort of
death of last resort that occurs after prolonged autophagy where
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the cell simply becomes exhausted and has no more resources
to combat prolonged stresses (Rami, 2009). This could occur by
a process of autophagosome lysis and subsequent death by the
releasedcatalyticallyactiveenzymesinaprocessanalogoustolyso-
somal rupture that occurs in some forms of ER stress or necrosis
(Orrenius et al., 2011). The application of proteomic approaches
to the study of autophagy may be useful in further delineating the
role of autophagy in cell death (Dengjel et al., 2012).
NECROSIS
Type III PCD is also known as necrosis. This cell death differs
from apoptosis in a number of readily detectable key features
including several biochemical, cellular, and morphological dif-
ferences (Berghe et al., 2010; Eisenberg et al., 2010; Fulda et al.,
2010; Galluzzi et al.,2012b). The early loss of membrane integrity
observedinnecroticcellscoupledtothefactthatmembraneexter-
nalization occurs in apoptosis allows the use to use ﬂuorescently
labeled nuclear vital dyes and differentially labeled protein capa-
ble of binding inner membranes (annexin V) to discriminate
between these forms of death. Also key among the differences
is the blebbing of apoptotic cells followed by the engulfment of
the debris by immune cells. Necrotic cells on other hand remain
within the tissue and lead to inﬂammation as they decay. Necro-
sis is the form of cell death that occurs in response to severe
catastrophic stress that leads to deleterious and irreversible cel-
lular injury. More recent studies suggest that there is a genetically
programmed form of necrosis, called necroptosis, which can be
triggered by severe stresses including some forms of DNA damage
(Weinlich et al., 2011; Wu et al., 2012). A biochemical pathway
involving the death type receptor (i.e., TNF-α) mediated forma-
tion of a necrosome type complex that leads to activation of
Receptor Interacting Protein Kinase 1 and 3 (RIPK-1 and 3) can
lead to both apoptotic and necrotic cell death (Green et al.,2011).
Compounds capable of inhibiting the RIPKs as well as poten-
tial intrinsically expressed proteins such as the prepro region of
cathepsin D have been identiﬁed as inhibitors of the process of
necroptosis (Carmona-Gutierrez et al., 2011a). These and other
studies suggest that clinical strategies aimed at preventing some
forms of necrosis may be possible (Christofferson and Yuan,
2010).
OTHER FORMS OF PCD
Alternative forms of apoptosis have been known for a long time
(Orrenius et al., 2011). There are non-traditional forms of PCD
that diverge due to a number of differences such as being caspase
or Bax independent (Kroemer et al., 2009). Other forms include
infectionswithorganismssuchasSalmonella thatinitiateacaspase
1 dependent cell death called pyroptosis. A caspase 12 dependent
process appears to be involved in certain forms of cell death such
as the pro-inﬂammatory condition that is seen in sepsis. Anoikis
refers to the PCD that occurs in response to cell detachment from
its neighbors. Increased resistance to this form of cell death may
lead to the ability to grow in an anchorage independent manner
that is often seen in cancer cells (Sakamoto and Kyprianou,2010).
Many of these PCDs appear to have characteristics of apoptosis
such as similar morphological changes indicating that many may
simplyrepresentvariantsonapoptosis.Thusdespitedifferencesin
triggering the many forms of PCDs,the mitochondria still plays a
central role in mediating many of these varied forms of cell death.
Even the PCD that occurs in aging, which shows a great deal of
dependence on glucose metabolism, appears to be dependent on
the mitochondria (Laun et al., 2008). Understanding how a cell
integrates all information to come up with the appropriate cell
death response will require more knowledge about the regulation
of cell death.
CROSS-TALK
All the different forms of PCD are not always stand-alone
processes. There is a great deal of reported cross-talk between
the different forms of cell death (Amelio et al., 2011; Giansanti
et al., 2011; Orrenius et al., 2011; Shen and Codogno, 2012). On
the large scale the three types of PCDs can be shown to inﬂu-
ence one another such that the process of autophagy can serve to
inhibitapoptosisandnecrosiswhilecellsunabletoundergoapop-
tosis will undergo autophagy or necrotic cell death (Zhivotovsky
and Orrenius, 2010; Shen and Codogno, 2012). The most highly
reported of such an example is the early experiment using MEFs
cultured from embryos having a double knock out (DKO) of the
two genes encoding the pro-apoptotic Bcl-2 proteins Bax and Bak
(Shimizu et al., 2004). The DKO embryos are lethal which likely
reﬂectstheimportanceofthesetwoproteinsinregulatingdevelop-
mental apoptosis. When challenged with apoptotic stimuli, DKO
MEFs appear to undergo a cell death that has the hallmarks not
of apoptosis but of autophagic cell death. On the other hand,
there are a number of other cases where the inhibition of caspase
can effectively prevent apoptotic cell death without sparring the
cell’s life since it induces necrosis (Rami et al.,2008).Alternatively
autophagy may be co-activated with apoptosis as a defense mech-
anism that can serve to prevent premature execution of apoptosis
or necrosis (Amelio et al., 2011; Shen and Codogno, 2012). These
and multiple other forms of cross-talk have been observed in a
number of different ways including the fact that many individ-
ual proteins play roles in more than one cell death modality. For
example, the BH3 containing Bcl-2 family member Beclin 1 is a
key regulator of autophagy that can be inhibited by Bcl-2 (Kang
et al., 2011). Thus Bcl-2 mediated inhibition of Beclin and of
Bax allows it to have direct roles in preventing autophagy and
apoptosis induction. On the other hand caspase mediated cleav-
age of Beclin can serve as a mechanism by which the activation of
apoptotic machinery can inhibit autophagy (Djavaheri-Mergny
et al., 2010). The regulation does not seem to be reciprocal since
the overexpression does not appear to inhibit the anti-apoptotic
effects of Bcl-2 (Kang et al., 2011). Other well-known examples
of proteins with dual functions include FLIP and the autophagic
speciﬁc gene ATG5 (Giansanti et al., 2011). FLIP is a well-known
inhibitor of the extrinsic apoptotic pathway that can also interact
with ATG3 and serve as a negative regulator of autophagy (Lee
et al., 2009). Less is known about possible cross-talk in unicel-
lular eukaryotes such as yeast. So although the three functional
PCDs exist in yeast,there will be a number of strategic differences
by which cross-talk between the pathways is used. For example,
the ATG6 gene serves the same autophagic regulatory function as
Beclin 1 but the yeast ortholog does not appear to have a BH3
domain.
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REGULATION OF PROGRAMMED CELL DEATH
INDUCTION
The most commonly examined form of cell death is the intrinsic
form of apoptosis that, as mentioned above, involves the stress
mediated release of pro-apoptogenic factors from the mitochon-
dria. This pathway mediates the effects of many of the stresses a
cell encounters including a wide range of chemicals and physical
agents as well as a myriad of others including intracellular stresses
suchasDNAdamage,ERstressaswellasthestimulithatoccursin
a large number of pathophysiological conditions (see below). The
proportion of cells that undergo apoptosis in a given population
of cells is directly related to the intensity of the stress encountered
(Figure 1; Orrenius et al., 2011; Qi et al., 2012). The intensity of
the stress is directly related to a combination of both the dose
encountered and the time of exposure to any given stress. For
example, keeping the time of exposure constant, we can decrease
the percentage of viable cells in a population by increasing the
FIGURE 1 | Stress is a dose dependent mediator of cell death. A
theoretical and graphical depiction of the effects of increasing the intensity
of stress on cellular viability. In a stress free environment cellular viability is
maintained close to 100% with only a basal level of cell death. In the normal
state (depicted in black), the percentage of cell viability begins to decreases
when a speciﬁc threshold of stress intensity is encountered. Intensity of
stress reﬂects a combination of time of exposure to the stress and to its
intensity. Cell death inducing stresses include a variety of different physical
or chemical agents or pathophysiological stresses as discussed in the text.
Once the threshold level of stress is encountered, the % viability further
decreases in dose dependent manner with respect to the increase in the
intensity of stress. In an apoptotic sensitive state (depicted in red), the
minimal threshold of the intensity of stress that is required in order to
observe a decrease in viability is reduced. Such an apoptotic sensitive state
can be observed in cells that are lacking mechanism that are involved in
apoptotic resistance such as the loss of an anti-apoptotic resistant gene or
a mutation leading to defects in the induction of autophagy. Alternatively,
overexpression of a pro-apoptotic gene can lead to a similar phenotype.The
opposite phenotype, that is the state of apoptotic resistance (depicted in
green), occurs in cells that are lacking some pro-apoptotic genes, that are
overexpressing an anti-apoptotic gene or that have increased activation of
other pro-survival processes such as autophagy.The net effect of altering a
cell’s sensitivity to apoptosis can be observed in the different intensity of
stress that is required to give rise to half maximal viability (50% viability,
depicted by dashed lines).Thus the threshold of sensitivity to death
inducing stress is variable and is established by complex regulatory
processes that involve both pro- and anti-apoptotic processes. It should be
noted that the processes that trigger apoptosis and that serve to induce
cell death are not altered by the apoptotic resistant or sensitive states.
concentration of the stress inducing agent. Thus the average cell
population under normal type conditions will respond in a dose
dependent manner to a stress and give a standard proﬁle of inten-
sity of stress vs. percentage viability that can be experimentally
determined (Figure 1). This proﬁle can shifted to the right or to
leftbyrespectivelyincreasingorreducingtheexpressionofanum-
ber of pro-apoptotic genes (Figure 1). Thus the normal response
to a given stress can be changed by altering the apoptotic machin-
ery.If thestressistoointense,accidentaldeathwilloccursincethe
cells will undergo necrosis.
Themechanismbywhichstressleadstotheactivationof apop-
totic response involves the increases in the levels of two well
characterized intermediates, activated Bax, and Reactive Oxygen
Species (ROS). Stress also results in an increases in the levels of a
number of other pro-apoptotic second messengers including cal-
cium,cAMP,the nucleotide dUTP,and the sphingolipid ceramide
(OzbayraktarandUlgen,2009;VertessyandToth,2009;Circuand
Aw, 2010; Ganesan and Colombini, 2010; Pourova et al., 2010;
Insel et al.,2011; Li et al.,2011; Orrenius et al.,2011;Wilson et al.,
2012).Increasesinthelevelofthesepro-apoptoticsecondmessen-
gers appear to be tightly coordinated and to be synergistic in their
effects (Portt et al.,2011;Ray et al.,2012). For example,increasing
activatedBaxleadstoincreasedROSandceramidewhileincreases
in ROS and ceramide can serve to activate Bax (Kumar and Jug-
dutt,2003; Lecour et al.,2006; Ganesan et al.,2010). Functionally,
onecanmanipulateadecreaseinthelevelsofROSorceramideand
this can serve to prevent Bax mediated cell death (see also below;
Moon et al., 2002; Yang et al., 2006; Separovic et al., 2007). This
suggests that stress mediated cell death involves the cooperative
response of numerous cellular pathways and that this cross-talk
may serve as redundant, additive, or even synergistic processes to
induce cell death (Portt et al., 2011). Speciﬁc recent examples of
additiveeffectsincludeBaxmediatedpermeabilizationoftheouter
mitochondrial membrane serving to increase the release of ROS
from the mitochondria. Increased levels of sphingolipids such as
ceramide in the mitochondrial membrane may in turn serve to
facilitate the insertion of Bax into the mitochondria (Ganesan
et al.,2010; Chipuk et al.,2012).
NEGATIVE REGULATORS OF PCD
In order to avoid triggering inappropriate PCD, cells have devel-
opedalargerepertoireofpro-survivaltoolsandstrategiesthatplay
critical roles in the balance between life and death (Owsianowski
etal.,2008;Buscaetal.,2009;Fuldaetal.,2010;Ashidaetal.,2011;
Porttetal.,2011;Rodriguesetal.,2012).Anti-apoptoticresponses
are not simply the inverse of apoptosis instead it is more like a
regulatory network that serves to prevent cell death when it is not
warranted. As we shall describe in the following few sections, this
network also includes and cross-talks extensively with the pro-
survival component of autophagy. Of further importance is the
factthatthisnetworkmaybepre-activatedinordertocreateastate
of increased resistance to future death inducing stimuli. Examples
oftheimportanceofthemodulatorynatureofapoptoticresponses
a r ew e l li l l u s t r a t e db yar e c e n tp a p e rb yShlezinger et al. (2011).
They examined the role that apoptosis and anti-apoptosis may
play in the ability of the necrotrophic fungus Botrytis cinerea to
infect plants. Using genetically altered organisms, they were able
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to show that plants send out signals to try and induce apoptosis in
the invader while an increase in the expression of anti-apoptotic
sequences in the fungus increased its ability to infect the plant.
Thus the ability to modulate responses to apoptotic stimuli can
be a useful tool in organisms with complex life cycles (Rodrigues
et al.,2012). Here we will focus on the major regulatory processes
that serve to negatively regulate PCD.
ANTI-APOPTOTIC GENES
Anti-apoptotic genes can be deﬁned as sequences that confer an
apoptotic resistant state to a cell while its knock out or a knock
down of its normal expression levels leads to a apoptotic sensi-
tive state (Figure 1). Exceptions may exist especially if the anti-
apoptotic gene functions in a parallel pathway to another similar
genes or processes. The most common anti-apoptotic gene,Bcl-2,
functions at least in part by antagonizing the pro-apoptotic Bcl-2
proteinBax(KhouryandGreenwood,2008).Otherverywellchar-
acterized anti-apoptotic proteins include the IAPs (Inhibitors of
Apoptosis),HSPs(HeatShockProteins),andROSscavengers.IAPs
functiontoinhibitcaspaseactivation;HSPsactaschaperonesthat
help in stabilizing protein structure while ROS scavengers serve in
inactivatingdamageinducingROS(Beere,2004;Buscaetal.,2009;
CircuandAw,2010).Thefunctionalanalysisofnewanti-apoptotic
genes often serves to reinforce the importance of some apoptotic
pathwaysortheymayservetouncovernovelones.Thustheimpor-
tance of ROS and misfolded/denatured proteins in the induction
of apoptosis from multiple stresses is reinforced by the classical
observationthatoverexpressionofgenesencodingROSscavengers
and chaperonin type HSPs serve to decrease cell death (Garrido
et al.,2003; Kim et al.,2006; Guaragnella et al.,2008). Uncovering
unexpected cell survival sequences such as the Metalloprotease 15
(MMP15) suggests a novel role for extracellular matrix or alter-
native functions to well-known proteins (Abraham et al., 2005).
The ability to increase cell survival by increasing the expression of
thegeneencodingdUTPasesupportstheemergingconsensusthat
nucleotides such as dUTP serve as stress-induced pro-apoptotic
second messengers (Williams et al., 2011; Wilson et al., 2012). On
the other hand, the cytoprotective effects of the ceramide utiliz-
ing enzyme sphingomyelin synthase is consistent with the long
standing role of ceramide as a stress-induced pro-apoptotic sec-
ondmessenger(Yangetal.,2006;Separovicetal.,2007,2008).The
diversity in the function of anti-apoptotic sequences exempliﬁes
the diverse roles played by these sequences.
Sequences capable of speciﬁcally preventing other forms of
PCD without effecting apoptotic cell death have been reported.
Thisisespeciallytruefortheabilityof genescapableof preventing
necroticcelldeath(Weinlichetal.,2011).Forexampledeathrecep-
tor mediated activation of receptor interacting protein kinases-1
and 3 (RIPK-1 and 3) is one of the early steps in the activation
of necroptosis. Proteins like FLIP are capable of inhibiting RIPKs
and preventing necroptosis and are thus functionally similar to
anti-apoptotic sequences (Green et al., 2011). Other examples of
such necroptotic regulators, is the ability of Pep4 (encoding the
yeast ortholog of the mammalian cathepsin D) to decrease aging
induced necrotic death (Carmona-Gutierrez et al., 2011a).
Ontheotherhandthereareanumberof genesthatcanbecon-
sidered as conditional anti-apoptotic genes. For example, there
are genes that serve to repair DNA damage in response to stresses
like UV light and thus can prevent cell death in response to DNA
damage. Most of these sequences are unable to prevent PCD in
responsetomostotherstresses.Sothesearepro-survivalgenesthat
represent stimulus dependent pro-survival anti-apoptotic genes.
Finally,there are a large number of genes that have been identiﬁed
that can prevent autophagy (Kroemer et al., 2009; Galluzzi et al.,
2012b). These genes are essential for autophagy and they func-
tion in the process of inducing autophagy, so their removal does
not in fact prevent autophagic cell death (He and Klionsky,2009).
The ability to prevent autophagic cell death is limited to a number
of non-speciﬁc pharmacological agents that mostly serve to pre-
vent acidiﬁcation of lysosomes. These are thought to function by
preventing similar processes in autophagolysosomes.
AUTOPHAGY AND OTHER PROTECTIVE PROCESSES
As mentioned above, basal autophagy serves as a housekeeping
processthatcangetridof damagedcellularconstituentsthataccu-
mulate while running the basic processes of cellular life. When
activated in response to stress, it can increase the removal of
damaged material and serve as a mechanism to prevent prema-
ture or inappropriate cell death (Shen and Codogno, 2012). Thus
the removal of damaged mitochondria can decrease stress medi-
ated increases in ROS levels while the removal of ER clogged
with denatured proteins can prevent unwanted ER stress medi-
ated PCD (Gottlieb et al., 2009). Thus a number of other more
specializedsub-formsofautophagysuchasmitophagymayalsobe
operational in preventing PCD (Kissova and Camougrand, 2010;
Marino et al.,2011).
Other cellular processes,analogous to autophagy,can also have
speciﬁc pro-survival functions in response to speciﬁc types of
stresses and are thus not always considered in general discussions
of cellular survival (Schonthal, 2009; Taylor and Rutter, 2011). A
commonexampleistheERstressresponse(Schonthal,2009).This
pathway is activated in response to stresses such as the accumula-
tion of misfolded proteins in the ER. Thus defects in this pathway
may account for pathological situations like Parkinson’s disease
(Nagley et al., 2010). Activating the ER stress response can serve
to prevent PCD is response to ER stress but it will be unable to
prevent general forms of PCD. Similar to ERAD,a stress inducible
mitochondrial quality control system (Mitochondrial-associated
degradation,MAD)hasrecentlybeendescribed(Heoetal.,2010).
ThisprocessinvolvesCdc48pandanewlyidentiﬁedCdc48pinter-
acting protein called VSM1. This process is thought to be able to
clean up damaged mitochondria and prevent cell death (Taylor
and Rutter, 2011).
PRO-SURVIVAL INTRACELLULAR SECOND MESSENGERS
Just as the regulation of cell death is a balance between pro- and
anti-apoptoticmachineries,itisof interestthatcellsproduceboth
anti- and pro- survival intracellular second messengers. ROS rep-
resents the classical second messenger regulator of apoptosis since
it can switch from being anti- to pro- apoptotic depending on
its levels (Ray et al., 2012). Similarly, cAMP also has the ability
to be both pro- and anti-apoptotic but that may be more depen-
d e n to nc e l lt y p e( Insel et al., 2011). One of the most interesting
but less studied intracellular secondary messenger is spermidine.
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Spermidine along with putrescine and spermine make up a fam-
ily of polyamine compounds that are ubiquitous and present in
high amounts in cells from bacteria, plants, and other eukaryotes
including man and yeast (Igarashi and Kashiwagi, 2010; Minois
et al., 2011). Although their exact function remains largely enig-
matic they are involved in a number of different cellular processes
including apoptosis (Igarashi and Kashiwagi, 2010; Minois et al.,
2011). In spite of the existence of a few reports demonstrat-
ing a pro-apoptotic effect of polyamines, their ability to serve as
anti-apoptotic agents appears to be more common (Igarashi and
Kashiwagi,2010;Gill and Tuteja,2011). The potential importance
of spermidine as a pro-survival and protective effector has been
increasedbytherecentreportshowingthatithasprotectiveeffects
in a number of different aging models including yeast, worm, ﬂy,
and mouse (Eisenberg et al.,2009). Of interest,the effects of sper-
midine appear to function by activating autophagy. The ability
to activate the protective effects of autophagy has been reported
for a number of compounds such as the anti-aging compound
resveratrol. This is widely attributed to be the anti-aging mediator
that is responsible for the reported beneﬁcial effects of red wine
(RockenfellerandMadeo,2010).Thisup-regulatingof autophagy
maybeacommonphenomenonasitisseenintheapoptoticresis-
tance associated with many pathophysiological conditions such as
cancer (see also below) and may also account for the pro-survival
effectsofawiderangeofotherconditions(Periyasamy-Thandavan
et al., 2009; Wilkinson and Ryan, 2010). Clues as to the mecha-
nisms involved in regulating the levels of protective spermidine
come from further studies of Madeo’s group who show the ability
of cathepsinDtopreventagingmediatednecroptosisisassociated
withanincreaseinpolyamines(Carmona-Gutierrezetal.,2011a).
HORMESIS AND PRE-CONDITIONING: ACTIVATION OF THE INTRINSIC
ANTI-APOPTOTIC PROGRAMS
Adaptationtostressesthatdonotleadtocelldeathinducesatran-
sientconditionwherethecellshowsanenhancedresistancetolater
exposure of otherwise lethal stresses (Balakumar et al., 2008; Le
Bourg,2009;Lehotskyetal.,2009;Calabreseetal.,2011a).Aseries
of experiments using yeast cells reported by Davies et al. (1995)
represent a simple but elegant demonstration of the processes of
pre-conditioning. They were able to show that a 2-h exposure to
3.2mM H2O2 was sufﬁcient to kill greater than 99.9% of yeast
cells. Cells that were pre-treated with a sub-lethal dose of H2O2,
say 0.1mM H2O2 for 45min,showed enhanced viability with 5%
of cells surviving in response to a later exposure 2h exposure to
3.2mM H2O2. This response was dose dependent with increasing
concentration of H2O2 used as pretreatment with 0.4mM lead-
ing to a greater than 30% viability following the 2-h exposure to
3.2mM H2O2. This and numerous other studies have shown that
there is a window of opportunity in which the protection occurs
and that the protection that is elicited in response to a sub-lethal
stress may lead to cross-protection and confer resistance to the
lethaleffectsof adifferentstress(BerryandGasch,2008;Calabrese
et al., 2011a). A similar process is seen in all cell types including
mammalianandbacterialcells.ThediagraminFigure1illustrates
in a simple schematic form, the differences that exist between the
responsesof acellina“NormalState”comparedtoanadaptedcell
that now has entered an“Apoptotic Resistant State.”The adapted
cellshowsanenhancedresistancetothecelldeathinducingeffects
of stress and this is demonstrated by the observation that they
require a greater dose of stress in order to kill off 50% of the pop-
ulation of cells (Figure 1). This process of adaptation induced by
mild stress that serves to increase resistance to stronger stress is
often referred to as a form of hormesis.As we will discuss later on,
hormesis is also likely to play an important role in our evolving
concept of the role ROS stress plays in the cell death that occurs in
processes such as aging.
ROLES FOR ROS, ANTI-APOPTOTIC GENES, AND AUTOPHAGY
An increase in the levels of ROS, albeit not as intense as observed
for cells undergoing apoptosis,plays a role in inducing the process
bywhichcellularadaptationoccursinresponsetomildstressseen
in hormesis and pre-conditioning (Martins et al., 2011; Ristow
and Schmeisser, 2011; Ristow and Zarse, 2011). As in apoptosis,
themitochondriaappeartobethemajorsourceofROSforhorme-
sis (Pan,2011). In contrast when ROS is present at physiologically
relevant levels such as observed during normal or mildly stressed
conditions, ROS functions as an intracellular second messenger
(Ray et al., 2012). The moderate increase in ROS levels can have
a number of effects on proteins for example, it can react with
cysteine residues and alter structure and the function of several
proteins (Ray et al., 2012). Thus ROS has been shown to be able
to alter a number of cellular responses by affecting a variety of
different pathways such as MAP and PI3 kinase cascades. The role
of ROS in mediating hormetic effects have been reported in all
organisms including bacteria. For example, the hormetic effect of
sub-lethal low levels of bactericidal antibiotic has been reported
to be mediated by increased levels of ROS (Belenky and Collins,
2011).
The free radical theory of aging is a long standing hypothesis
thathasbeenusedtoexplainaging(Harman,1956).Atitssimplest,
the theory posits that free radicals accumulate during the aging
process and this accounts for the increased damage that accumu-
lates at the cellular,tissue,and organismal level (Ristow and Zarse,
2011). First proposed in the 1950s the hypothesis gained a lot of
momentum as it made a lot of inherent sense and it was con-
sistent with many observations. It is so widely accepted, even by
the general public, that anti-oxidants such as vitamin C and E are
commonly accepted anti-aging components of most anti-aging
creams. The theory of increased free radicals was also commonly
adopted as a mechanism to explain the damage that occurs in
responsetonumerouspathophysiologicalstressesincludingmany
that lead to cell death (Kumar et al., 2002; Misra et al., 2009).
Thus anti-oxidants were examined for their potential to prevent
cellular death in multiple diseases including numerous forms of
cardiomyopathies. Numerous discrepancies uncovered over the
years have served to question the validity of the model. Of impor-
tance to this skepticism was the effect of calorie restriction (CR)
on aging. CR, without malnutrition, had been widely reported
to slow down aging and lead to increased longevity in all species
examinedincludingyeast,ﬂies,worms,andmammals(Ristowand
Zarse, 2011). An excess production of ROS has not been able to
fullyexplaintheeffectsofCR.Instead,CRappearstoactlikeamild
stress leading to moderate increases in ROS levels and subsequent
anti-aging effects that are mediated by hormesis (Martins et al.,
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2011; Ristow and Schmeisser, 2011; Ristow and Zarse, 2011). The
similarities between CR and hormesis include up-regulating the
same pro-survival strategies including increases in the expression
of anti-apoptotic sequences and activation of autophagy (Cal-
abreseetal.,2011a;Martinsetal.,2011).Insupportof this,arethe
widespread observations that the anti-aging effects mediated by
otherprocessessuchastheremovalofspeciﬁcgenesandtheeffects
of compoundslikeresveratrolandspermidinefunction,atleastin
part,byincreasingstressresponseandautophagy(Calabreseetal.,
2011a). For example the loss of the CTA1 catalase encoding gene
in yeast serves to extend chronological lifespan by increasing the
levelsof ROSinamanneranalogoustoCR(Mesquitaetal.,2010).
Other stress inducible pro-apoptotic second messengers such
as ceramide may also have dual functions in regulating cell death
responses (Lecour et al.,2005). Of interest,sub-lethal increases in
ROSmayalsoaccountfortheincreasedautophagythatisobserved
in many scenarios involving mildly stressed cells. This suggests
that there is a mechanism for the direct cross-talk between dif-
ferent forms of pro-survival processes. Other evidence for such
cross-talk comes from the recent observations that some anti-
apoptoticgenesmayfunctionbyactivatingautophagy(Gurusamy
et al., 2009; Qian et al., 2009). An alternative scenario to explain
the later observation is based on the fact that the overexpression
of a number of genes is mildly toxic and they serve to stress the
cell (Liu et al., 1992). For example, it is well-known that cells
used in the biotechnology industry that are forced by genetic
manipulations to overexpress different gene products are often
stressed to the point where they undergo apoptotic like cell death
(Krampe and Al-Rubeai, 2010; Mokdad-Gargouri et al., 2012).
It could thus be envisioned that some anti-apoptotic genes pre-
vent cell death due the fact that their overexpression leads to mild
stress and subsequent induction of the pro-survival machinery
including activation of autophagy and hormesis. Other scenar-
ios that serve to induce a protective pre-condition or hormetic
phenotype include the loss by knockout of some genes as well as
number of different compounds including many toxic chemicals
administered at sub-lethal levels (Kharade et al.,2005;Wang et al.,
2009; Mesquita et al., 2010; Martins et al., 2011; Orrenius et al.,
2011). This indicates that there are multitudes of ways of elicit-
ing a protective phenotype. This serves to increase the repertoire
of strategies that can be clinically used to combat unwanted cell
death (Fleming et al.,2011).
ONE GENE CAN RECAPITULATE THE ENTIRE PROCESS OF HORMESIS
Analysis of the expression of numerous genes, and more recently
the analysis of global gene expression proﬁles, reveal that cellu-
lar adaptation (pre-conditioning and hormesis) is associated with
alterationsintheexpressionofmanygenesincludingtheincreased
expression of a number of anti-apoptotic genes (Wu et al., 2004;
Coles et al., 2005; Balakumar et al., 2008; Fulda, 2009b). In spite
of the fact that that the expression of so many different genes are
observed, a stress resistant phenotype can be recapitulated by the
simple overexpression of a multitude of different but individual
anti-apoptotic genes (Gil-Gómez and Brady, 1998; Yenari et al.,
2005; Khan et al., 2006; Nakka et al., 2008). The fact that a single
gene is sufﬁcient for this phenotype suggests that there is a strong
redundancy in the numerous anti-apoptotic processes that are
invoked in the process of adaptation. Increased autophagy,proba-
blymacro-autophagy,isalsoaresponsetomildstress.Similarlyto
what is observed with the increased expression of anti-apoptotic
genes,increasedautophagyonitsowniscapableofincreasingpro-
survival phenotypes. This can be demonstrated by using speciﬁc
macro-autophagy activating drugs like rapamycin (Galluzzi et al.,
2012a). Such cells show increased resistance to numerous stresses
including many that would be sufﬁcient to induce apoptosis. One
of the questions that remain is why there is so much apparent
redundancy and co-activation of anti-apoptotic and pro-survival
responses.
In eukaryotic microbes, pre-conditioning is a process that has
numerous similarities to hormesis. Classical pre-conditioning can
be demonstrated by temporally decreasing blood supply to a tis-
sue leading to mild ischemia like conditions (Balakumar et al.,
2008; Porter et al., 2012). As in hormesis, the mildly stressed tis-
sue can be subsequently shown to have acquired an increased
resistance to more intense levels of stress including longer peri-
ods of ischemia. The normal form of pre-conditioning called
late onset pre-conditioning involves an increase in the expres-
sion of anti-apoptotic genes and is likely to be similar if not
identical to what occurs during hormesis (as described above).
There is also an early form of cellular protection that occurs soon
after the pre-conditioning stimuli. This process is much quicker
than the late onset form of pre-conditioning and usually involves
post-translational mechanisms that serve to activate pro-survival
proteinsandcascadessuchasMAPkinases(Hausenloyetal.,2005;
Balakumar et al., 2008). The question as to whether such an early
form of hormesis exists in yeast has not been fully addressed.
DISEASES ASSOCIATED WITH ALTERED PCD
CONDITIONS WITH INCREASED RESISTANCE TO APOPTOSIS
Thereaplethoraof diseasesandpathophysiologiesthatareassoci-
ated with defective apoptotic responses (Krakstad and Chekenya,
2010;Whelanetal.,2010;ZhivotovskyandOrrenius,2010;Ashida
et al.,2011; Lavu et al.,2011; Liu et al.,2011; Orrenius et al.,2011;
Strasser et al., 2011; Ulukaya et al., 2011; Oerlemans et al., 2012;
Porter et al.,2012). Some such as cancer and some virally infected
cellshavedecreasedapoptoticresponsesthatleadtotheaccumula-
tionofunwantedcells.Theseconditionallyapoptoticresistantcells
havebeenusefulinidentifyinggeneswhoseup-regulationcancon-
fer anti-apoptotic phenotypes (Busca et al., 2009; Fulda, 2009b).
In effect, the most common anti-apoptotic gene, Bcl-2, was ﬁrst
identiﬁed as a gene that is up-regulated in cancer cells (Vaux et al.,
1988). Altered Bcl-2 levels are now known to occur in a large pro-
portion of cancers. Developing combinational chemotherapeutic
strategiesaimedatkillingcancercellscombinedwithinhibitorsof
anti-apoptotic genes or of their protein product are being devel-
oped as useful clinical processes (Strasser et al., 2011). Cancer
cellsdevelopinstressfulmicro-environmentsthatcanincludelow
nutrient and oxygen levels (Fulda, 2010). Strategies aimed at pre-
venting new blood vessel formation (angiogenesis) are based on
preventing the establishment of these tumor cells (Galluzzi et al.,
2010b). These types of stresses faced by cancer cells is thought
to lead to pre-condition or hormesis like responses that serve to
increase apoptotic resistance (Fulda, 2009b; Fulda et al., 2010).
Thus there is also an increase in other cell survival strategies in
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these cells including an increase in autophagy that accounts for
some of the anti-apoptotic responses (Liu et al., 2011; Meschini
et al.,2011). These observations have led to the current interest in
thedevelopmentof autophagyinhibitorstobeusedaschemother-
apeutic adjuvants (Wilkinson and Ryan, 2010; Meschini et al.,
2011).
CONDITIONS SHOWING ENHANCED APOPTOSIS
On the other hand, there are a large number of other pathophys-
iological conditions where an increase in cell death occurs (Fulda
et al., 2010; Whelan et al., 2010; Ulukaya et al., 2011). These are
seeninresponsetostressessuchasischemia/reperfusionthatoccur
duetoheartattacksandstrokes,inautoimmunediseaseslikeMul-
tiple Sclerosis (MS), and in diseases associated with defects of
protein folding and quality control leading to the accumulation
of misfolded proteins such as occurs in Alzheimer’s disease. In
unicellular eukaryotes such as yeast, exposure to excess mating
pheromone in the absence of an appropriate mating partner or
the heterologous expression of disease causing human genes like
α-synuclein can be seen as analogous to pathological situations
that lead to premature death (Buttner et al.,2006; Franssens et al.,
2010; Khurana and Lindquist,2010). In more practical situations,
inappropriate, or unwanted cell death occurs in industrially used
cells including yeast and cultured mammalian cells that undergo
apoptosis due to the stresses imposed by the forced overproduc-
tionofbiotechnologicallyimportantcompoundsandtherapeutics
(Krampe and Al-Rubeai, 2010; Mokdad-Gargouri et al., 2012).
In many pathologies, there are very limited therapies given that
the underlying causes of many of these diseases are not known.
Increased apoptosis is not usually the cause since it occurs as a
result of the stress a cell encounters due to the pathophysiologi-
cal condition. Nevertheless, the ability to prevent PCD following
the onset of the disease process could be of tremendous clini-
cal value. This is apparent for the PCD that occurs after acute
conditions like a heart attack following an ischemic/reperfusion
event(Oerlemans et al.,2012). The most common form of a heart
attack involves a blockage of a blood vessel leading to ischemic
event that leads to nutrients and oxygen deprivation stress of the
cells downstream of the obstruction (Ong and Gustafsson, 2012;
Figure 2). The ﬁrst priority is to unblock the blood vessel and
allow tissue reperfusion (Porter et al., 2012). The level of stress is
graded with the most severe stress occurring in the cells that are
most deprived of blood (Figure 2). In addition, there is a great
deal of stress that occurs in the cells due to the effects of reper-
fusion (Ong and Gustafsson, 2012). Necrosis is likely to occur
in the part of the tissue that is severely deprived, while apopto-
sis is triggered in some other areas having less stress (Ong and
Gustafsson, 2012). Thus there is a zone of necrotic death that
likely occurs soon after a heart attack and these cells are likely
beyond therapeutic rescue (Figure 2). Conversely, cell death due
toPCD(apoptoticandpossiblyautophagicdeath),willoccurover
the next few days (Ong and Gustafsson, 2012). Thus there is a
therapeutic window in which the prevention of PCD would be a
great beneﬁt in limiting the infarct size, increasing survivability
and decreasing morbidity, following ischemia/reperfusion events.
Thus the process of post-conditioning can be used to prevent
some of the post-infarct induced PCD (Balakumar et al., 2008;
Lehotsky et al., 2009). Post-conditioning refers to the ability to
stimulate a hormetic like response in cells using chemical agents
thatcaninducepre-conditioningevenaftertheapoptosisinducing
event has occurred (Balakumar et al.,2008; Lehotsky et al.,2009).
Further, there is a great deal of evidence that serves to convince
that therapeutic interference in the process of PCD post-infarct
would serve to limit cellular demise (Oerlemans et al., 2012).
Of importance here is the observation that transgenic animals
that overexpress anti-apoptotic genes in a cardiac or brain spe-
ciﬁcmanner,havesigniﬁcantlydecreasedzonesof deathfollowing
ischemic events (Figure 2; Yenari et al., 2005; Khan et al., 2006;
Nakka et al., 2008). These effects are widespread since they are
observed with a number of different anti-apoptotic genes and it
demonstrates the potential clinical usefulness of anti-apoptosis
(Rami et al., 2008; Fulda, 2009a; Krakstad and Chekenya, 2010;
Dietz,2011; Lavu et al.,2011).
CLINICAL APPROACHES AND DEVELOPMENT OF APOPTOTIC
REGULATING THEARAPEUTICS
Numerousstrategieshavebeendevelopedinordertotryandover-
cometheapoptoticresistanceencounteredincancercells(Strasser
et al., 2011; Porter et al., 2012). Most chemotherapeutics as well
as radiation therapies appear to function by targeting the rapidly
dividing phenotype associated with these cells in order to induce
a speciﬁc apoptotic response.As mentioned above,strategies such
as the inhibition of autophagy,are being developed to render can-
cer cells more sensitive to apoptotic inducing stimuli. In the case
of cells that are more resistant to apoptosis due to an infection
by an infective agent, investigations are underway to understand
the life cycle of these organisms to target the factors that increase
apoptotic resistance (Galluzzi et al., 2010a; Ashida et al., 2011;
Rodrigues et al.,2012).
On the other hand, given the success achieved by overexpress-
inganti-apoptoticgenesintransgenicanimalstopreventischemic
damage,there is intense investigation to try and develop strategies
that can serve to inhibit apoptosis (Rami et al., 2008; Yacoubian
and Standaert, 2009; Dietz, 2011; Oerlemans et al., 2012). Thus
thedevelopmentof smallmoleculeinhibitorsof proteinsinvolved
in mediating apoptotic death was examined by many (Oerlemans
et al., 2012). Given their central role in apoptosis, caspases were
identiﬁed as ideal targets given that their inhibition is predicted to
serve to prevent at least some forms of PCD. Caspase inhibitors
with a good deal of speciﬁcity and effectiveness were developed
and shown to be effective in vitro cell cultures (Oerlemans et al.,
2012). Many of the inhibitors were indeed effective at blocking
caspase and caspase mediated cell death. In contrast these were of
limited effectiveness at preventing cell death in vivo (Oerlemans
etal.,2012).Itappearsthatcellsthatarestimulatedwithappropri-
ate stress will undergo alternate modes of PCD if their apoptotic
machinery is impaired. This situation is commonly observed and
is reminiscent of the autophagic cell death that occurs in apoptot-
ically stimulated cells that are unable to undergo apoptosis due to
a double KO of the pro-apoptotic Bcl-2 family members Bax and
Bak (Shimizu et al.,2004).
The limited effectiveness encountered with these caspase
inhibitors suggests that targeting a single protein may not be able
to inhibit apoptosis. Thus a great deal of effort is being made
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FIGURE2|S c hematic depiction of the stress generated and
subsequent cell death mediated by cardiac stress events. Zones of
cardiac cell death can be induced experimentally including the generation
of myocardial infarction (MI) by ligation of left descending artery or by
direct cardiac ischemia reperfusion (Tarnavski et al., 2004). In the normal
state (left side), a gradient of stress intensity occurs in the deprived tissue
where the most severely deprived cells undergo necrosis while other
stressed cells undergo cell death that appears to include apoptosis and
possibly autophagic death. Loss of viability is more pronounced as we
move closer to the site of the most intense stress.Transgenic animals that
overexpress an anti-apoptotic gene in a cardiac speciﬁc manner represent
an apoptotic resistant state (right side). Identical levels of stress generated
in the hearts of these animals leads to signiﬁcant reduction in the zone of
dead cells.
into understanding the processes that occur during apoptosis and
anti-apoptosisinordertodevelopstrategiesaimedattappinginto
thenaturalanti-apoptoticnetwork(Balakumaretal.,2008;Lehot-
sky et al., 2009; Lochner et al., 2009; Yacoubian and Standaert,
2009; Boll et al., 2011). This concept is in line with the fact that
agents causing up-regulation of endogenous defense mechanisms
by hormesis or by pre-conditioning are effective at preventing or
decreasing cell death (Balakumar et al., 2008; Rami et al., 2008;
Calabrese et al., 2011b; Martins et al., 2011; Porter et al., 2012).
Thus,anti-apoptoticgenes,whicharepartof theinvivo regulatory
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responsestocounteractstressmediatedcelldeath,arereadilyeffec-
tive when overexpressed in vivo (via transgenics; Gil-Gómez and
Brady, 1998; Yenari et al., 2005; Khan et al., 2006). Strategies are
currently being developed to increase the levels of anti-apoptotic
genes in tissues. Approaches include delivery of expressible gene
constructs by gene therapy or the use of lipophilically modiﬁed
recombinant proteins that could diffuse into apoptotically chal-
lengedcells(Dietz,2011;Lavuetal.,2011).Suchapproachescould
only serve to give rise to a short term increase in the levels of anti-
apoptotic proteins,but this may be sufﬁcient to prevent cell death
intheshorttermafteranischemic/reperfusioneventintissueslike
the heart.
YEAST AS A MODEL TO STUDY PCD
In addition to its long history in the food and biotechnology
industries, the yeast S. cerevisiae may be the most widely used
model organism (Botstein and Fink, 2011). As a eukaryotic cell
system it has numerous advantages over other model cell types
including the ability to use genetic approaches. In addition, its
basic cellular processes, such as cell cycle control, DNA replica-
tion and repair, mitochondrial based respiration, and autophagy
are carried out by simpliﬁed cellular process that are virtually
interchangeable with the same but more complex processes of
metazoan eukaryotes including humans (Perocchi et al., 2008).
Thus it comes as no surprise that the description of a PCD in
S. cerevisiae in 1997 has led to an explosion of research into the
study of these processes in yeast (Madeo et al., 1997; Carmona-
Gutierrez et al., 2010). Although the utility of a PCD process in
unicellular eukaryotes was at ﬁrst difﬁcult to imagine, it is now
widely accepted and has in fact been extensively documented to
occur in a wide variety of different unicellular eukaryotes (She-
marova, 2010). Over the last few years, a large variety of studies
have been instrumental in documenting many of the processes
and in identifying many of the proteins involved in mediating
yeast PCD (Frohlich et al.,2007; Carmona-Gutierrez et al.,2010).
Although there are some differences, it would appear that yeast
PCD is very similar to the mitochondrial or intrinsic apoptosis
seen in metazoans (Eisenberg et al., 2007; Pereira et al., 2008).
The complexity is decreased compared to mammalian apoptosis
which is exempliﬁed by the fact that most apoptotic regulators are
encoded by multiple copies in humans but by single copy genes in
yeast. So, yeast has single functional counterparts to many mam-
malian apoptotic regulators including a caspase (YCA1), a BH3
containing Bcl-2 family like protein (yBH3), an AIF (AIF), an
OMI serine protease (NMA111), and an Endonuclease G (NUC1;
Madeo et al., 2002; Fahrenkrog et al., 2004; Wissing et al., 2004;
Buttner et al., 2007, 2011). As in mammalian cells, yeast will
undergo apoptosis in response to a variety of different stresses
including many chemicals, physical process such as altered osmo-
larity and pH, as well as the overexpression of genes encoding
pro-apoptotic proteins including mammalian Bax and caspases
(Manon et al., 1997; Lisa-Santamaria et al., 2009; Sharon et al.,
2009; Carmona-Gutierrez et al., 2010; Orrenius et al., 2011). The
intracellular events mediating yeast PCD also show a great deal of
similarity with a number of other processes such as an increase
in mitochondrial outer membrane permeability, increase in pro-
apoptoticsecondmessengerslikeROSandceramide,thereleaseof
apoptogenic factors including cytochrome c, DNA fragmentation
as well as the externalization of phosphatidylserine (Manon et al.,
1997;Ligretal.,1998;Madeoetal.,1999;Yangetal.,2006;Ganesan
et al., 2010; Carmona-Gutierrez et al., 2011b). In addition, natu-
rally occurring physiological processes including ER stress and
chronological aging will lead to mitochondrial and necrotic like
celldeathasitdoesinmammaliancells(Burhansetal.,2003;Fab-
rizio and Longo, 2008; Winderickx et al., 2008; Eisenberg et al.,
2010;Madeoetal.,2010;Pan,2011).Ontheotherhand,ERmedi-
ated cell death in yeast is reminiscent of what occurs in a number
of diseases that involves the accumulation of misfolded proteins
such as Parkinson’s and Huntington’s (Winderickx et al., 2008;
Khurana and Lindquist, 2010).
Of importance to our interests is the fact that regulated cell
death, including PCD and necrosis, in yeast is also under neg-
ative regulation (Owsianowski et al., 2008; Carmona-Gutierrez
et al., 2011a; Zdralevic et al., 2012). In fact many of the proteins
that are known to prevent cell death in mammalian cells, such
as free radical scavengers, chaperonin type proteins like HSPs,
the yeast IAP (Inhibitor of Apoptosis Protein) protein (Bir1p)
as well as numerous heterologous mammalian proteins such as
Bcl-2 also prevent cell death (Manon et al., 1997; Moon et al.,
2002; Flower et al., 2005; Walter et al., 2006). Yeast also has a
well-deﬁnedstressactivatedautophagicprocessthathaslongbeen
known to promote cellular longevity in response to stresses such
as amino acid or glucose starvation and aging (Eisenberg et al.,
2009; He and Klionsky, 2009). In spite of this, there have been
very relatively few studies directed toward examining the possible
role of autophagic cell death in yeast (Camougrand et al., 2003;
Kissovaetal.,2006;Thevissenetal.,2010;Sampaio-Marquesetal.,
2011).
Observed differences between yeast and mammalian cells are
alsoof interest.Forexample,inascreenforyeastmutantsshowing
increased resistance to the heterologous expression of the pro-
apoptotic Bax,the UTH1 gene was identiﬁed (Camougrand et al.,
2004).Althoughtheexactfunctionof Uth1phasyettobedeﬁned,
deletion of this gene leads to a number of interesting pleiotropic
effects including increasing replicative lifespan, increasing resis-
tancetotheautophagicinducingdrugrapamycinandERinducing
stresses (Kissova and Camougrand, 2010; Ritch et al., 2010). Sur-
prisingly, a direct mammalian ortholog of UTH1 h a sy e tt ob e
found but it would be of interest to set up a suicide screen of
UTH1Δ cells in order to identify potential functional homologs.
Such screens have proven useful in the past for the identiﬁcation
and characterization of a number different human orthologs that
can functionally complement phenotypes of a variety of differ-
ent yeast mutants (Perier et al., 1994; Sato et al., 2006; Osborn
and Miller, 2007). The study of yeast speciﬁc apoptotic regu-
lators open up possibilities of increasing our understanding of
the basic ancestral processes involved in regulating PCD. More
recent developments including systems biology and other global
approaches are being applied to understanding the processes of
PCD in yeast (Munoz et al., 2012). For example a global search
for yeast genes that are potential regulators of PCD was carried
out by evaluating all yeast gene knockout strains for increased
susceptibility to stress mediated cell death (Teng et al., 2011).
Over 800 of the 6000 or so yeast genes were thus identiﬁed as
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FIGURE3|S c hematic depiction of a yeast based functional strategy to
screen for and identify cardiac speciﬁc sequences capable of preventing
Bax mediated cell death. Poly A
+ RNA isolated from human cardiac tissue
was used to generate a cDNA library in the URA3 selectable marker yeast
expression plasmid pYES-DEST52 (Sato et al., 2006).This places the
expression of the human cardiac cDNAs under the control of the galactose
inducible GAL1 promoter. Plasmid pGILDA-Bax was used to express an
activated mouse Bax in yeast under the control of galactose inducible GAL1
promoter.Yeast cells harboring pGILDA-Bax alone show normal growth when
grown on glucose media but undergo cell death due to the expression of Bax
when grown on galactose media. Close to 10
6 yeast transformants harboring
both pGILDA-Bax as well as different cDNAs from the pYES-DEST52 cardiac
cDNA library were grown on galactose media. A total of 72 different colonies
containing over 60 different putative Bax suppressors were identiﬁed when
the pYES-DEST52 cardiac cDNAs were isolated and their nucleotide sequence
determined (Yang et al., 2006). Similar apoptotic resistant phenotypes can be
achieved in the heart by subjecting the tissue to a period of mild stress in
order to induce pre-conditioning. Glu, glucose; GAL, galactose.
potentialpro-apoptoticgenes.Thissuggeststhatmanymoregenes
are involved in the process of PCD than we know of now and
these types of approaches in yeast may actually serve to identify
all players in the process of PCD. Other such global strategies are
now being combined with the power of yeast genetics to char-
acterize other processes involved in PCD such as identifying the
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metabolic products (metabolome) that accumulate in different
process associated with different forms of PCD (Ring et al.,2012).
HUMANIZED YEAST
Humanized yeast has been extensively used to study the structure
and function of human genes in an uncluttered cellular envi-
ronment (Osborn and Miller, 2007; Greenwood and Ludovico,
2010; Silva et al., 2011a). For example, all mammalian cells
express a multitude of G-Protein Coupled Receptors (GPCRs)
and studies focused on individual members of this large gene
family are further encumbered by the fact that different mem-
bers of the same family are capable of functionally interact-
ing with each other (Panetta and Greenwood, 2008). Thus the
ability to functionally replace the yeast sex pheromone GPCRs
and their regulatory proteins with human orthologs allows the
study of individual human genes uncluttered by the presence
of other members (Kong et al., 2002; Ladds et al., 2005). Given
the similarity between the processes of metazoan mitochondri-
ally induced apoptosis and yeast apoptosis (Cheng et al., 2008)
it is not surprising that humanized yeast have been successfully
usedinthepursuitof knowledgeregardingthegenesinvolvedand
the processes regulating PCD (Greenwood and Ludovico, 2010;
Khurana and Lindquist, 2010; Silva et al., 2011a; Zdralevic et al.,
2012).
Earlystudiesbyanumberofyeastresearchersleadtothediscov-
erythatmammalianregulatorsofapoptosisincludingvariousBcl-
2familymembersincludingpro-apoptoticBaxandanti-apoptotic
Bcl-2 could be functionally expressed in yeast (Greenhalf et al.,
1996; Manon et al., 1997; Tao et al., 1997). Thus Bax mediated
PCD in yeast was extensively studied and all indications sug-
gested it induced apoptosis, at least in some cells, since it lead to
apoptotic hallmark events similar to what was observed in mam-
malian cells (Priault et al., 2003; Khoury et al., 2008). Bcl-2 was
also able to prevent Bax as well as other forms of stress medi-
ated PCD in yeast. Some of these early studies had noticed that
Bax expression not only lead to typical apoptotic phenotypes but
it also lead to the activation of autophagy (Camougrand et al.,
2003; Kissova et al., 2006). This is indicative of some form of
cross-talkandissuggestiveofsomeoftheusefulavenuesofknowl-
edge that are uncovered using humanized yeast in the study of
PCD. Not surprisingly other pro-apoptotic human proteins such
as caspases can trigger the same types of effects in yeast (Lisa-
Santamaria et al., 2009). The functional expression of Bax and
of other mammalian apoptotic regulators continues to serve to
uncover insights into PCD (Greenwood and Ludovico, 2010).
In the case of Bax, recent work has been useful in characteriz-
ing the roles of a variety of different proteins including protein
kinase C and the mitochondrial receptor Tom22 in the functional
activation of Bax (Renault et al., 2011; Silva et al., 2011b). Up
until recently it was thought that the yeast genome did not code
for any BH3 containing proteins, so the effects of heterologously
expressed Bcl-2 proteins was thought to reﬂect intrinsic activi-
ties of these proteins or it was thought that yeast must contain a
functional that is a not structural homolog of human Bax (Priault
et al., 2003; Khoury et al., 2008). More recently, an endogenously
encodedBH3domaincontainingprotein,calledyBH3p,wasiden-
tiﬁed as a pro-apoptotic protein in yeast (Buttner et al., 2011).
Whether it has all the functions of mammalian Bax remains to be
determined.
Bax mediated lethality in yeast was exploited in other ways.
Notably,yeastcellsconditionallyexpressingBax,mostoftenunder
a galactose inducible promoter, were used in numerous suicide
screens (Figure 3; Liu et al., 1992; Sato et al., 2006; Osborn
and Miller, 2007; Greenwood and Ludovico, 2010). Copy DNA
(cDNA)librariesobtainedfromarangeofdifferentspeciesinclud-
ing bacteria, plants, and different tissues were screened in order
to identify sequences that permitted yeast to grow in the pres-
ence of Bax (Greenwood and Ludovico,2010; Laloux et al.,2010).
Many of the Bax suppressors identiﬁed corresponded to obvi-
ous anti-apoptotic sequences including numerous free radical
scavenging proteins (Kampranis et al., 2000; Moon et al., 2002;
Camougrand et al., 2004). This is consistent with the notion that
Bax is indeed inducing a PCD that has similarities to apopto-
sis. Other proteins identiﬁed represent a challenge since they are
clearly able to prevent PCD from a number of different stresses in
yeast, but the mechanism by which they carry out this function
remains unknown. This class of protein includes some with well-
known functions such as Vacuolar Protein Sorting 24 (VPS24)
andthesmallGTPbindingproteinRanaswellasproteinsthatare
essentially functional orphans including TMEM85 and TMEM14
(Khouryetal.,2007;Ringetal.,2008;Wooetal.,2008,2011).Other
Bax suppressors identiﬁed include the dUTP hydrolyzing enzyme
dUTPase and the ceramide utilizing enzyme sphingomyelin syn-
thase (Yang et al., 2006; Williams et al., 2011). This suggests that
stress mediated cell death in yeast, like observed in mammalian
cells, involves an up-regulation of the levels of apoptosis induc-
ingsecondmessengersincludingROS,ceramide,anddUTP(Portt
etal.,2011;Wilsonetal.,2012).Manyof thescreenshavereported
the identiﬁcation of multiple Bax suppressors but the identity of
many of these have yet to be reported. For example screening of
a human T cell library lead to the identiﬁcation or 24 Bax sup-
pressors but the group has only reported a detailed analysis of
four of these (Eun et al., 2008; Woo et al., 2008, 2009, 2011). Sim-
ilarly, we have isolated over 60 different Bax suppressors from a
screen of a human cardiac library and we have since published a
detailedcharacterizationof ﬁveof these(Yangetal.,2006;Khoury
et al., 2007, 2008; Ring et al., 2008; Williams et al., 2011). Paral-
lel or subsequent analysis of a number of these Bax suppressors
reveal that they are bone-ﬁde cell survival genes since they also
function as anti-apoptotic genes in mammalian cells (Fiol et al.,
2007;Separovicetal.,2007;Eunetal.,2008;Wooetal.,2008,2009,
2011; Greenwood and Ludovico, 2010; Williams et al., 2011; Wil-
sonetal.,2012).Takentogetherthesescreenssuggeststhatthereis
alotmorethatremainstobediscoveredontheanti-apoptoticand
cell survival mechanisms used by a cell and that yeast is an ideal
system for this task.
ACKNOWLEDGMENTS
Space prevented us from citing the work from all the many lab-
oratories that have made signiﬁcant contributions to the ﬁeld of
anti-apoptosisandcellsurvival.WorkinMTG’slaboratoryissup-
portedbyNSERC,theARPprogramattheRoyalMilitaryCollege,
andajointgrantwithCAMfromtheHeartandStrokeFoundation
of Canada.
Frontiers in Oncology | Molecular and Cellular Oncology June 2012 | Volume 2 | Article 59 | 12Clapp et al. Anti-apoptosis in humanized yeast
REFERENCES
Abraham, R., Schafer, J., Rothe, M.,
Bange, J., Knyazev, P., and Ullrich,
A. (2005). Identiﬁcation of MMP-
15 as an anti-apoptotic factor in
cancer cells. J. Biol. Chem. 280,
34123–34132.
Amelio,I.,Melino,G.,and Knight,R.A.
(2011). Cell death pathology: cross-
talk with autophagy and its clinical
implications. Biochem. Biophys. Res.
Commun. 414, 277–281.
Ashida, H., Mimuro, H., Ogawa, M.,
Kobayashi, T., Sanada, T., Kim, M.,
and Sasakawa, C. (2011). Cell death
andinfection:adouble-edgedsword
for host and pathogen survival. J.
Cell Biol. 195, 931–942.
Balakumar, P., Rohilla, A., and Singh,
M. (2008). Pre-conditioning and
postconditioning to limit ischemia-
reperfusion-induced myocardial
injury: what could be the next
footstep? Pharmacol. Res. 57,
403–412.
Beere, H. M. (2004). “The stress of
dying”: the role of heat shock pro-
teins in the regulation of apoptosis.
J. Cell Sci. 117, 2641–2651.
Belenky, P., and Collins, J. J. (2011).
Microbiology.Antioxidantstrategies
to tolerate antibiotics. Science 334,
915–916.
Berghe, T. V., Vanlangenakker, N.,
Parthoens, E., Deckers, W., Devos,
M.,Festjens,N.,Guerin,C.J.,Brunk,
U. T., Declercq, W., and Vanden-
abeele,P.(2010).Necroptosis,necro-
sis and secondary necrosis con-
verge on similar cellular disintegra-
tion features. Cell Death Differ. 17,
922–930.
Berry, D. B., and Gasch, A. P. (2008).
Stress-activated genomic expression
changes serve a preparative role for
impending stress in yeast. Mol. Biol.
Cell 19, 4580–4587.
Boll, M. C., Alcaraz-Zubeldia, M., and
Rios, C. (2011). Medical manage-
mentofParkinson’sdisease:focuson
neuroprotection. Curr. Neurophar-
macol. 9, 350–359.
Botstein, D., and Fink, G. R. (2011).
Yeast: an experimental organism for
21st Century biology. Genetics 189,
695–704.
Burhans, W. C., Weinberger, M., Mar-
chetti, M. A., Ramachandran, L.,
D’Urso, G., and Huberman, J. A.
(2003). Apoptosis-like yeast cell
death in response to DNA damage
and replication defects. Mutat. Res.
532, 227–243.
Busca, A., Saxena, M., Kryworuchko,
M., and Kumar, A. (2009). Anti-
apoptotic genes in the survival of
monocytic cells during infection.
Curr. Genomics 10, 306–317.
Buttner, S., Eisenberg, T., Carmona-
Gutierrez, D., Ruli, D., Knauer, H.,
Ruckenstuhl, C., Sigrist, C., Wiss-
ing, S., Kollroser, M., Frohlich, K.
U., Sigrist, S., and Madeo, F. (2007).
Endonuclease G regulates budding
yeast life and death. Mol. Cell 25,
233–246.
Buttner, S., Eisenberg, T., Herker, E.,
Carmona-Gutierrez, D., Kroemer,
G., and Madeo, F. (2006). Why yeast
cellscanundergoapoptosis:deathin
times of peace, love, and war. J. Cell
Biol. 175, 521–525.
Buttner, S., Ruli, D., Vogtle, F. N., Gal-
luzzi, L., Moitzi, B., Eisenberg, T.,
Kepp, O., Habernig, L., Carmona-
Gutierrez, D., Rockenfeller, P., Laun,
P., Breitenbach, M., Khoury, C.,
Frohlich, K. U., Rechberger, G.,
Meisinger, C., Kroemer, G., and
Madeo, F. (2011). A yeast BH3-only
protein mediates the mitochondrial
pathway of apoptosis. EMBO J. 30,
2779–2792.
Calabrese, V., Cornelius, C., Cuzzocrea,
S., Iavicoli, I., Rizzarelli, E., and Cal-
abrese, E. J. (2011a). Hormesis, cel-
lular stress response and vitagenes
as critical determinants in aging
and longevity. Mol. Aspects Med. 32,
279–304.
Calabrese, V., Cornelius, C., Dinkova-
Kostova, A. T., Calabrese, E. J., and
Mattson, M. P. (2011b). Cellular
stress responses, the hormesis par-
adigm, and vitagenes: novel targets
for therapeutic intervention in neu-
rodegenerative disorders. Antioxid.
Redox Signal. 13, 1763–1811.
Camougrand, N., Grelaud-Coq, A.,
Marza, E., Priault, M., Bessoule, J.
J., and Manon, S. (2003). The prod-
uct of the UTH1 gene, required
for Bax-induced cell death in
yeast, is involved in the response
to rapamycin. Mol. Microbiol. 47,
495–506.
Camougrand, N., Kissova, I., Velours,
G., and Manon, S. (2004). Uth1p:
a yeast mitochondrial protein at
the crossroads of stress,degradation
and cell death. FEMS Yeast Res. 5,
133–140.
Carmona-Gutierrez, D., Bauer, M. A.,
Ring, J., Knauer, H., Eisenberg, T.,
Buttner, S., Ruckenstuhl, C., Reisen-
bichler, A., Magnes, C., Rechberger,
G. N.,Birner-Gruenberger,R.,Jung-
wirth, H., Frohlich, K. U., Sinner, F.,
Kroemer,G.,and Madeo,F. (2011a).
The propeptide of yeast cathepsin D
inhibits programmed necrosis. Cell
Death Dis. 2, e161.
Carmona-Gutierrez, D., Reisenbichler,
A., Heimbucher, P., Bauer, M. A.,
Braun, R. J., Ruckenstuhl, C., But-
tner, S., Eisenberg, T., Rockenfeller,
P., Frohlich, K. U., Kroemer, G.,
and Madeo, F. (2011b). Ceramide
triggers metacaspase-independent
mitochondrial cell death in yeast.
Cell Cycle 10, 3973–3978.
Carmona-Gutierrez, D., Eisenberg, T.,
Buttner, S., Meisinger, C., Kroemer,
G., and Madeo, F. (2010). Apoptosis
in yeast: triggers, pathways, subrou-
tines. Cell Death Differ. 17,763–773.
Carmona-Gutierrez, D., and Madeo,
F. (2009). “Tracing the roots of
death: apoptosis in Saccharomyces
cerevisiae,” in Essentials of Apoptosis,
2nd Edn,eds Z. Dong and X. M.Yin
(Dusseldorf: Springer), 325–354.
Chen, Y., and Klionsky, D. J. (2011).
Theregulationofautophagy–unan-
swered questions. J. Cell Sci. 124,
161–170.
Cheng, W. C., Leach, K. M., and Hard-
wick, J. M. (2008). Mitochondrial
death pathways in yeast and mam-
malian cells. Biochim. Biophys. Acta
1783, 1272–1279.
Chipuk, J. E., McStay, G. P., Bharti, A.,
Kuwana, T., Clarke, C. J., Siskind,
L. J., Obeid, L.M., and Green, D.
R. (2012). Sphingolipid metabolism
cooperates with BAK and BAX to
promotethemitochondrialpathway
of apoptosis. Cell 148, 988–1000.
Christofferson, D. E., and Yuan, J.
(2010). Necroptosis as an alter-
native form of programmed cell
death. Curr. Opin. Cell Biol. 22,
263–268.
Circu,M. L.,andAw,T.Y. (2010). Reac-
tive oxygen species, cellular redox
systems, and apoptosis. Free Radic.
Biol. Med. 48, 749–762.
Coles, J. G., Boscarino, C., Takahashi,
M., Grant, D., Chang, A., Ritter, J.,
Dai, X., Du, C., Musso, G., Yam-
abi, H., Goncalves, J., Kumar, A.
S., Woodgett, J., Lu, H., and Han-
nigan, G. (2005). Cardioprotective
stress response in the human fetal
heart. J. Thorac. Cardiovasc. Surg.
129, 1128–1136.
Davies, J. M., Lowry, C. V., and Davies,
K. J. (1995). Transient adaptation
to oxidative stress in yeast. Arch.
Biochem. Biophys. 317, 1–6.
Dengjel, J., Hoyer-Hansen, M., Nielsen,
M. O., Eisenberg, T., Harder, L.
M., Schandorff, S., Farkas, T.,
Kirkegaard, T., Becker, A. C.,
Schroeder, S., Vanselow, K., Lund-
berg, E., Nielsen, M. M., Kris-
tensen, A. R., Akimov, V., Bunken-
borg, J., Madeo, F., Jaattela, M., and
Andersen, J. S. (2012). Identiﬁca-
tion of autophagosome-associated
proteins and regulators by quantita-
tive proteomic analysis and genetic
screens. Mol. Cell. Proteomics 11,
M111 014035.
Denton, D., Nicolson, S., and Kumar,
S. (2012). Cell death by autophagy:
facts and apparent artefacts. Cell
Death Differ. 19, 87–95.
Dietz,G.P.(2011).Protectionbyneuro-
globin and cell-penetrating peptide-
mediated delivery in vivo: a decade
of research. Comment on Cai et al:
TAT-mediated delivery of neuroglo-
bin protects against focal cerebral
ischemia in mice. Exp. Neurol. 227,
224–231. [Exp. Neurol. 231, 1–10].
Djavaheri-Mergny, M., Maiuri, M. C.,
and Kroemer, G. (2010). Cross talk
betweenapoptosisandautophagyby
caspase-mediated cleavage of Beclin
1. Oncogene 29, 1717–1719.
Eisenberg, T., Buttner, S., Kroemer, G.,
and Madeo, F. (2007). The mito-
chondrial pathway in yeast apopto-
sis. Apoptosis 12, 1011–1023.
Eisenberg, T., Carmona-Gutierrez, D.,
Buttner, S., Tavernarakis, N., and
Madeo, F. (2010). Necrosis in yeast.
Apoptosis 15, 257–268.
Eisenberg, T., Knauer, H., Schauer,
A., Buttner, S., Ruckenstuhl, C.,
Carmona-Gutierrez, D., Ring,
J., Schroeder, S., Magnes, C.,
Antonacci, L., Fussi, H., Deszcz, L.,
Hartl, R., Schraml, E., Criollo, A.,
Megalou, E., Weiskopf, D., Laun,
P., Heeren, G., Breitenbach, M.,
Grubeck-Loebenstein, B., Herker,
E., Fahrenkrog, B., Frohlich, K. U.,
Sinner, F., Tavernarakis, N., Minois,
N., Kroemer, G., and Madeo, F.
(2009). Induction of autophagy
by spermidine promotes longevity.
Nat. Cell Biol. 11, 1305–1314.
Eun, S. Y., Woo, I. S., Jang, H. S., Jin,
H., Kim, M. Y., Kim, H. J., Lee,
J. H., Chang, K. C., Kim, J. H.,
and Seo, H. G. (2008). Identiﬁ-
cation of cytochrome c oxidase
subunit 6A1 as a suppressor of Bax-
induced cell death by yeast-based
functional screening. Biochem.
Biophys. Res. Commun. 373,
58–63.
Fabrizio, P., and Longo, V. D. (2008).
Chronological aging-induced apop-
tosis in yeast. Biochim. Biophys. Acta
1783, 1280–1285.
Fahrenkrog, B., Sauder, U., and Aebi,
U. (2004). The S. cerevisiae HtrA-
like protein Nma111p is a nuclear
serine protease that mediates yeast
apoptosis. J. Cell Sci. 117, 115–126.
Fiol, D. F., Mak, S. K., and Kultz, D.
(2007).SpeciﬁcTSC22domaintran-
scripts are hypertonically induced
and alternatively spliced to protect
mouse kidney cells during osmotic
stress. FEBS J. 274, 109–124.
Fleming,A.,Noda,T.,Yoshimori,T.,and
Rubinsztein, D. C. (2011). Chem-
ical modulators of autophagy as
www.frontiersin.org June 2012 | Volume 2 | Article 59 | 13Clapp et al. Anti-apoptosis in humanized yeast
biologicalprobesandpotentialther-
apeutics. Nat. Chem. Biol. 7, 9–17.
Flower, T. R., Chesnokova, L. S.,
Froelich, C. A., Dixon, C., and Witt,
S. N. (2005). Heat shock prevents
alpha-synuclein-induced apoptosis
in a yeast model of Parkinson’s dis-
ease. J. Mol. Biol. 351, 1081–1100.
Franssens, V., Boelen, E., Anandhaku-
mar, J., Vanhelmont, T., Buttner,
S., and Winderickx, J. (2010). Yeast
unfolds the road map toward alpha-
synuclein-induced cell death. Cell
Death Differ. 17, 746–753.
Frohlich, K. U., Fussi, H., and Ruck-
enstuhl, C. (2007). Yeast apopto-
sis – from genes to pathways. Semin.
Cancer Biol. 17, 112–121.
Fulda, S. (2009a). Tumor resistance
to apoptosis. Int. J. Cancer 124,
511–515.
Fulda, S. (2009b). Exploiting apoptosis
pathways for the treatment of pedi-
atric cancers. Pediatr. Blood Cancer
53, 533–536.
Fulda,S.(2010).Evasionof apoptosisas
a cellular stress response in cancer.
Int. J. Cell Biol. 2010, 370835.
Fulda, S., Gorman, A. M., Hori, O.,
andSamali,A.(2010).Cellularstress
responses: cell survival and cell
death. Int. J. Cell Biol. 2010, 214074.
Galluzzi,L.,Kepp,O.,Morselli,E.,Vitale,
I., Senovilla, L., Pinti, M., Zitvo-
gel, L., and Kroemer, G. (2010a).
Viral strategies for the evasion of
immunogenic cell death. J. Intern.
Med. 267, 526–542.
Galluzzi,L.,Morselli,E.,Kepp,O.,Vitale,
I.,Rigoni,A.,Vacchelli,E.,Michaud,
M., Zischka, H., Castedo, M., and
Kroemer, G. (2010b). Mitochondr-
ial gateways to cancer. Mol. Aspects
Med. 31, 1–20.
Galluzzi,L.,Morselli,E.,Kepp,O.,Vitale,
I., Younes, A. B., Maiuri, M. C.,
andKroemer,G.(2012a).Evaluation
of rapamycin-induced cell death.
Methods Mol. Biol. 821, 125–169.
Galluzzi, L., Vitale, I., Abrams, J. M.,
Alnemri, E. S., Baehrecke, E. H.,
Blagosklonny, M. V., Dawson, T.
M., Dawson, V. L., El-Deiry, W.
S., Fulda, S., Gottlieb, E., Green,
D. R., Hengartner, M. O., Kepp,
O., Knight, R. A., Kumar, S., Lip-
ton, S. A., Lu, X., Madeo, F., Mal-
orni, W., Mehlen, P., Nunez, G.,
Peter, M. E., Piacentini, M., Rubin-
sztein, D. C., Shi, Y., Simon, H.
U., Vandenabeele, P., White, E.,
Yuan, J., Zhivotovsky, B., Melino, G.,
and Kroemer, G. (2012b). Molec-
ular deﬁnitions of cell death sub-
routines: recommendations of the
Nomenclature Committee on cell
death 2012. Cell Death Differ. 19,
107–120.
Ganesan,V.,and Colombini,M. (2010).
Regulation of ceramide channels by
Bcl-2familyproteins.FEBSLett.584,
2128–2134.
Ganesan, V., Perera, M. N., Colombini,
D., Datskovskiy, D., Chadha, K., and
Colombini, M. (2010). Ceramide
and activated Bax act synergisti-
cally to permeabilize the mitochon-
drial outer membrane. Apoptosis 15,
553–562.
Garrido, C., Schmitt, E., Cande, C.,
Vahsen, N., Parcellier, A., and Kroe-
mer, G. (2003). HSP27 and HSP70:
potentially oncogenic apoptosis
inhibitors. Cell Cycle 2, 579–584.
Giansanti, V., Torriglia, A., and Sco-
vassi, A. I. (2011). Conversation
between apoptosis and autophagy:
“Is it your turn or mine?” Apoptosis
16, 321–333.
Gil-Gómez, G., and Brady, H. J.
(1998).Transgenicmiceinapoptosis
research. Apoptosis 3, 215–228.
Gill, S. S., and Tuteja, N. (2011).
Polyamines and abiotic stress toler-
anceinplants.PlantSignal.Behav.5,
26–33.
Gottlieb, R. A., Finley, K. D., and
Mentzer, R. M. Jr. (2009). Car-
dioprotection requires taking out
the trash. Basic Res. Cardiol. 104,
169–180.
Green, D. R., Oberst, A., Dillon, C.
P., Weinlich, R., and Salvesen, G.
S. (2011). RIPK-dependent necro-
sis and its regulation by caspases: a
mystery in ﬁve acts. Mol. Cell 44,
9–16.
Greenhalf,W., Stephan, C., and Chaud-
huri, B. (1996). Role of mito-
chondriaandC-terminalmembrane
anchor of Bcl-2 in Bax induced
growth arrest and mortality in Sac-
charomycescerevisiae.FEBSLett.380,
169–175.
Greenwood, M. T., and Ludovico, P.
(2010). Expressing and functional
analysis of mammalian apoptotic
regulators in yeast. Cell Death Differ.
17, 737–745.
Guaragnella, N., Antonacci, L., Gian-
nattasio, S., Marra, E., and Pas-
sarella, S. (2008). Catalase T and
Cu,Zn-superoxide dismutase in the
acetic acid-induced programmed
cell death in Saccharomyces cere-
visiae. FEBS Lett. 582, 210–214.
Gurusamy, N., Lekli, I., Gherghiceanu,
M., Popescu, L. M., and Das, D. K.
(2009). BAG-1 induces autophagy
for cardiac cell survival. Autophagy
5, 120–121.
Harman, D. (1956). Aging: a theory
based on free radical and radiation
chemistry. J. Gerontol. 11, 298–300.
Hausenloy, D. J., Tsang, A., Mocanu,
M. M., and Yellon, D. M. (2005).
Ischemic preconditioning protects
by activating prosurvival kinases at
reperfusion. Am. J. Physiol. Heart
Circ. Physiol. 288, H971–H976.
He, C., and Klionsky, D. J. (2009). Reg-
ulation mechanisms and signaling
pathways of autophagy. Annu. Rev.
Genet. 43, 67–93.
Heo, J. M., Livnat-Levanon, N., Taylor,
E. B., Jones, K. T., Dephoure, N.,
Ring,J.,Xie,J.,Brodsky,J.L.,Madeo,
F., Gygi, S. P., Ashraﬁ, K., Glickman,
M.H.,andRutter,J.(2010).Astress-
responsivesystemformitochondrial
protein degradation. Mol. Cell 40,
465–480.
Hotchkiss, R. S., Strasser, A., McDunn,
J. E., and Swanson, P. E. (2009).
Cell death. N .E n g l .J .M e d .361,
1570–1583.
Igarashi, K., and Kashiwagi, K. (2010).
Modulation of cellular function by
polyamines.Int.J.Biochem.CellBiol.
42, 39–51.
Insel, P. A., Zhang, L., Murray, F., Yok-
ouchi,H.,andZambon,A.C.(2011).
Cyclic AMP is both a pro-apoptotic
and anti-apoptotic second messen-
ger.ActaPhysiol(Oxf.)204,277–287.
Kaczanowski, S., Sajid, M., and Reece,
S. E. (2011). Evolution of apoptosis-
like programmed cell death in uni-
cellular protozoan parasites. Parasit.
Vectors 4, 44.
Kampranis, S. C., Damianova, R., Atal-
lah, M., Toby, G., Kondi, G., Tsich-
lis, P. N., and Makris, A. M.
(2000). A novel plant glutathione
S-transferase/peroxidase suppresses
Bax lethality in yeast. J. Biol. Chem.
275, 29207–29216.
Kang, R., Zeh, H. J., Lotze, M. T., and
Tang, D. (2011). The Beclin 1 net-
workregulatesautophagyandapop-
tosis. Cell Death Differ. 18, 571–580.
Khan,A.A.,Wang,Y.,Sun,Y.,Mao,X.O.,
Xie, L., Miles, E., Graboski, J., Chen,
S., Ellerby, L. M., Jin, K., and Green-
berg, D. A. (2006). Neuroglobin-
overexpressing transgenic mice are
resistant to cerebral and myocar-
dial ischemia. Proc. Natl. Acad. Sci.
U.S.A. 103, 17944–17948.
Kharade, S. V., Mittal, N., Das, S. P.,
Sinha,P.,and Roy,N. (2005). Mrg19
depletionincreasesS.cerevisiae lifes-
pan by augmenting ROS defence.
FEBS Lett. 579, 6809–6813.
Khoury, C. M., and Greenwood, M.
T. (2008). The pleiotropic effects
of heterologous Bax expression in
yeast. Biochim. Biophys. Acta 1783,
1449–1465.
Khoury, C. M., Yang, Z., Ismail, S., and
Greenwood, M. T. (2007). Charac-
terization of a novel alternatively
spliced human transcript encoding
an N-terminally truncated Vps24
protein that suppresses the effects
of Bax in an ESCRT independent
mannerinyeast.Gene 391,233–241.
Khoury,C.M.,Yang,Z.,Li,X.Y.,Vignali,
M.,Fields,S.,and Greenwood,M. T.
(2008). A TSC22-like motif deﬁnes
anovelantiapoptoticproteinfamily.
FEMS Yeast Res. 8, 540–563.
Khurana, V., and Lindquist, S. (2010).
Modelling neurodegeneration in
Saccharomyces cerevisiae:w h yc o o k
with baker’s yeast? Nat. Rev. Neu-
rosci. 11, 436–449.
Kim, H. J., So, H. S., Lee, J. H., Park,
C., Park, S. Y., Kim, Y. H., Youn,
M. J., Kim, S. J., Chung, S. Y., Lee,
K. M., and Park, R. (2006). Heme
oxygenase-1attenuatesthecisplatin-
induced apoptosis of auditory cells
via down-regulation of reactive oxy-
gen species generation. Free Radic.
Biol. Med. 40, 1810–1819.
Kissova, I., Plamondon, L. T., Bris-
son, L., Priault, M., Renouf, V.,
Schaeffer, J., Camougrand, N., and
Manon, S. (2006). Evaluation of
the roles of apoptosis, autophagy
and mitophagy in the loss of plat-
ing efﬁciency induced by Bax-
expression in yeast. J. Biol. Chem.
281, 36187–36197.
Kissova, I. S., and Camougrand, N.
(2010). Mitophagy in yeast: actors
and physiological roles. FEMS Yeast
Res. 10, 1023–1034.
Kong, J. L., Panetta, R., Song, W.,
Somerville, W., and Greenwood, M.
T.(2002).Inhibitionofsomatostatin
receptor 5-signaling by mammalian
Regulators of G-protein Signaling
(RGS) in yeast. Biochim. Biophys.
Acta 1542, 95–105.
Krakstad, C., and Chekenya, M. (2010).
Survival signalling and apoptosis
resistance in glioblastomas: oppor-
tunities for targeted therapeutics.
Mol. Cancer 9, 135.
Krampe, B., and Al-Rubeai, M. (2010).
Cell death in mammalian cell cul-
ture:molecularmechanismsandcell
lineengineeringstrategies.Cytotech-
nology 62, 175–188.
Kroemer, G., Galluzzi, L., Vanden-
abeele, P., Abrams, J., Alnemri, E.
S., Baehrecke, E. H., Blagosklonny,
M. V., El-Deiry, W. S., Golstein,
P., Green, D. R., Hengartner, M.,
Knight, R. A., Kumar, S., Lipton, S.
A.,Malorni,W.,Nunez,G.,Peter,M.
E., Tschopp, J., Yuan, J., Piacentini,
M., Zhivotovsky, B., and Melino, G.
(2009). Classiﬁcation of cell death:
recommendationsof theNomencla-
ture Committee on cell death 2009.
Cell Death Differ. 16, 3–11.
Kumar, D., and Jugdutt, B. I. (2003).
Apoptosis and oxidants in the heart.
J. Lab. Clin. Med. 142, 288–297.
Frontiers in Oncology | Molecular and Cellular Oncology June 2012 | Volume 2 | Article 59 | 14Clapp et al. Anti-apoptosis in humanized yeast
Kumar, D., Lou, H., and Singal, P. K.
(2002). Oxidative stress and apop-
tosis in heart dysfunction. Herz 27,
662–668.
Ladds, G., Goddard, A., and Davey, J.
(2005). Functional analysis of het-
erologous GPCR signalling path-
ways in yeast. Trends Biotechnol. 23,
367–373.
Laloux, G., Deghelt, M., de Barsy, M.,
Letesson, J. J., and De Bolle, X.
(2010). Identiﬁcation of the essen-
tialBrucellamelitensis porinOmp2b
as a suppressor of Bax-induced cell
death in yeast in a genome-wide
screening. PLoS ONE 5, e13274.
doi:10.1371/journal.pone.0013274
Laun, P., Heeren, G., Rinnerthaler, M.,
Rid, R., Kossler, S., Koller, L., and
Breitenbach, M. (2008). Senescence
and apoptosis in yeast mother cell-
speciﬁc aging and in higher cells: a
short review. Biochim. Biophys. Acta
1783, 1328–1334.
Lavu, M., Gundewar, S., and Lefer, D.
J. (2011). Gene therapy for ischemic
heartdisease.J.Mol.Cell.Cardiol.50,
742–750.
Le Bourg, E. (2009). Hormesis, aging
and longevity. Biochim. Biophys.
Acta 1790, 1030–1039.
Lecour, S., Owira, P., and Opie, L. H.
(2005). Ceramide-induced precon-
ditioning involves reactive oxygen
species. Life Sci. 78, 1702–1706.
Lecour, S., Van der Merwe, E., Opie,
L. H., and Sack, M. N. (2006).
Ceramide attenuates hypoxic cell
deathviareactiveoxygenspeciessig-
naling. J. Cardiovasc. Pharmacol. 47,
158–163.
Lee, J. S., Li, Q., Lee, J. Y., Lee, S.
H., Jeong, J. H., Lee, H. R., Chang,
H., Zhou, F. C., Gao, S. J., Liang,
C., and Jung, J. U. (2009). FLIP-
mediated autophagy regulation in
cell death control. Nat. Cell Biol. 11,
1355–1362.
Lehotsky, J., Burda, J., Danielisova, V.,
Gottlieb, M., Kaplan, P., and San-
iova, B. (2009). Ischemic tolerance:
the mechanisms of neuroprotective
strategy. Anat. Rec. (Hoboken) 292,
2002–2012.
Li, Z. Y., Yang, Y., Ming, M., and Liu,
B. (2011). Mitochondrial ROS gen-
eration for regulation of autophagic
pathways in cancer. Biochem. Bio-
phys. Res. Commun. 414, 5–8.
Ligr, M., Madeo, F., Frohlich, E., Hilt,
W., Frohlich, K. U., and Wolf, D.
H. (1998). Mammalian Bax triggers
apoptotic changes in yeast. FEBS
Lett. 438, 61–65.
Lisa-Santamaria, P., Neiman, A. M.,
Cuesta-Marban, A., Mollinedo, F.,
Revuelta, J. L., and Jimenez, A.
(2009). Human initiator caspases
trigger apoptotic and autophagic
phenotypes in Saccharomyces cere-
visiae. Biochim. Biophys. Acta 1793,
561–571.
Liu, H., Krizek, J., and Bretscher, A.
(1992). Construction of a GAL1-
regulated yeast cDNA expression
library and its application to the
identiﬁcation of genes whose over-
expression causes lethality in yeast.
Genetics 132, 665–673.
Liu, J. J., Lin, M., Yu, J. Y., Liu, B., and
Bao,J.K.(2011).Targetingapoptotic
and autophagic pathways for can-
cer therapeutics. Cancer Lett. 300,
105–114.
Lochner, A., Marais, E., Genade, S.,
Huisamen, B., du Toit, E. F., and
Moolman, J. A. (2009). Protection
oftheischaemicheart:investigations
into the phenomenon of ischaemic
preconditioning. Cardiovasc. J. Afr.
20, 43–51.
Loewith, R., and Hall, M. N. (2011).
Targetof rapamycin(TOR)innutri-
ent signaling and growth control.
Genetics 189, 1177–1201.
Madeo, F., Eisenberg, T., Buttner,
S., Ruckenstuhl, C., and Kroemer,
G. (2010). Spermidine: a novel
autophagy inducer and longevity
elixir. Autophagy 6, 160–162.
Madeo, F., Frohlich, E., and Frohlich,
K. U. (1997). A yeast mutant show-
ing diagnostic markers of early and
late apoptosis. J. Cell Biol. 139,
729–734.
Madeo, F., Frohlich, E., Ligr, M., Grey,
M., Sigrist, S. J., Wolf, D. H., and
Frohlich, K. U. (1999). Oxygen
stress: a regulator of apoptosis in
yeast. J. Cell Biol. 145, 757–767.
Madeo, F., Herker, E., Maldener, C.,
Wissing, S., Lachelt, S., Herlan, M.,
Fehr, M., Lauber, K., Sigrist, S. J.,
Wesselborg, S., and Frohlich, K. U.
(2002). A caspase-related protease
regulatesapoptosisinyeast.Mol.Cell
9, 911–917.
Manon, S., Chaudhuri, B., and Guerin,
M. (1997). Release of cytochrome c
and decrease of cytochrome c oxi-
dase in Bax-expressing yeast cells,
and prevention of these effects by
coexpression of Bcl-xL. FEBS Lett.
415, 29–32.
Marino, G., Madeo, F., and Kroemer, G.
(2011). Autophagy for tissue home-
ostasis and neuroprotection. Curr.
Opin. Cell Biol. 23, 198–206.
Martins, I., Galluzzi, L., and Kroe-
mer, G. (2011). Hormesis, cell death
and aging. Aging (Albany N.Y.) 3,
821–828.
Meschini,S.,Condello,M.,Lista,P.,and
Arancia,G.(2011).Autophagy:mol-
ecular mechanisms and their impli-
cations for anticancer therapies.
Curr Cancer Drug Targets 11,
357–379.
Mesquita, A., Weinberger, M., Silva,
A., Sampaio-Marques, B., Almeida,
B., Leao, C., Costa, V., Rodrigues,
F., Burhans, W. C., and Ludovico,
P. (2010). Caloric restriction or
catalase inactivation extends yeast
chronological lifespan by inducing
H2O2 and superoxide dismutase
activity. Proc. Natl. Acad. Sci. U.S.A.
107, 15123–15128.
Minois,N.,Carmona-Gutierrez,D.,and
Madeo, F. (2011). Polyamines in
aging and disease. Aging (Albany
N.Y.) 3, 716–732.
Misra, M. K., Sarwat, M., Bhakuni, P.,
Tuteja, R., and Tuteja, N. (2009).
Oxidative stress and ischemic
myocardial syndromes. Med. Sci.
Monit. 15, RA209–RA219.
Mokdad-Gargouri, R., Abdelmoula-
Soussi, S., Hadiji-Abbès, N., Amor,
I. Y., Borchani-Chabchoub, I., and
Gargouri, A. (2012). Yeasts as a tool
for heterologous gene expression.
Methods Mol. Biol. 824, 359–370.
Moon, H., Baek, D., Lee, B., Prasad, D.
T., Lee, S. Y., Cho, M. J., Lim, C. O.,
Choi, M. S., Bahk, J., Kim, M. O.,
Hong, J. C., and Yun, D. J. (2002).
Soybean ascorbate peroxidase sup-
presses Bax-induced apoptosis in
yeast by inhibiting oxygen radical
generation. Biochem. Biophys. Res.
Commun. 290, 457–462.
Moreau,K.,Luo,S.,and Rubinsztein,D.
C. (2009). Cytoprotective roles for
autophagy. Curr. Opin. Cell Biol. 22,
206–211.
Munoz,A.J.,Wanichthanarak,K.,Meza,
E., and Petranovic, D. (2012). Sys-
tems biology of yeast cell death.
FEMS Yeast Res. 12, 249–265.
Nagley, P., Higgins, G. C., Atkin, J. D.,
andBeart,P.M.(2010).Multifaceted
deaths orchestrated by mitochon-
dria in neurones. Biochim. Biophys.
Acta 1802, 167–185.
Nakka, V. P., Gusain, A., Mehta, S. L.,
and Raghubir, R. (2008). Molecular
mechanisms of apoptosis in cere-
bralischemia:multipleneuroprotec-
tive opportunities. Mol. Neurobiol.
37, 7–38.
Oerlemans, M. I., Koudstaal, S.,
Chamuleau, S. A., de Kleijn, D.
P., Doevendans, P. A., and Slui-
jter, J. P. (2012). Targeting cell
death in the reperfused heart:
pharmacological approaches for
cardioprotection. Int. J. Cardiol.
doi:10.1016/j.ijcard.2012.03.055
Ong, S. B., and Gustafsson, A. B.
(2012). New roles for mitochon-
dria in cell death in the reperfused
myocardium. Cardiovasc. Res. 94,
190–196.
Orrenius, S., Nicotera, P., and Zhivo-
tovsky, B. (2011). Cell death mech-
anisms and their implications in
toxicology. Toxicol. Sci. 119, 3–19.
Osborn, M. J., and Miller, J. R. (2007).
Rescuing yeast mutants with human
genes. Brief. Funct. Genomic. Pro-
teomic. 6, 104–111.
Owsianowski, E., Walter, D., and
Fahrenkrog, B. (2008). Negative
regulation of apoptosis in yeast.
Biochim. Biophys. Acta 1783,
1303–1310.
Ozbayraktar, F. B., and Ulgen, K.
O. (2009). Molecular facets of
sphingolipids:mediatorsof diseases.
Biotechnol. J. 4, 1028–1041.
Pan, T., Rawal, P., Wu, Y., Xie, W.,
Jankovic, J., and Le, W. (2009).
Rapamycin protects against
rotenone-induced apoptosis
through autophagy induction.
Neuroscience 164, 541–551.
Pan, Y. (2011). Mitochondria, reactive
oxygen species, and chronological
aging: a message from yeast. Exp.
Gerontol. 46, 847–852.
Panetta, R., and Greenwood, M.
T. (2008). Physiological relevance
of GPCR oligomerization and its
impact on drug discovery. Drug Dis-
cov. Today 13, 1059–1066.
Pereira, C., Silva, R. D., Saraiva,
L., Johansson, B., Sousa, M.
J., and Corte-Real, M. (2008).
Mitochondria-dependent apoptosis
in yeast. Biochim. Biophys. Acta
1783, 1286–1302.
Perier, F., Coulter, K. L., Liang, H.,
Radeke, C. M., Gaber, R. F., and
Vandenberg,C.A.(1994).Identiﬁca-
tion of a novel mammalian member
of the NSF/CDC48p/Pas1p/TBP-1
familythroughheterologousexpres-
sion in yeast. FEBS Lett. 351,
286–290.
Periyasamy-Thandavan, S., Jiang,
M., Schoenlein, P., and Dong, Z.
(2009). Autophagy: molecular
machinery, regulation, and impli-
cations for renal pathophysiology.
Am. J. Physiol. Renal Physiol. 297,
F244–F256.
Perocchi,F.,Mancera,E.,andSteinmetz,
L. M. (2008). Systematic screens for
human disease genes, from yeast to
human and back. Mol. Biosyst. 4,
18–19.
Porter, K., Medford, H. M., McIntosh,
C. M., and Marsh, S. A. (2012).
Cardioprotection requires ﬂipping
the ‘posttranslational modiﬁcation’
switch. Life Sci. 90, 89–98.
Portt,L.,Norman,G.,Clapp,C.,Green-
wood, M., and Greenwood, M. T.
(2011). Anti-apoptosis and cell sur-
vival: a review. Biochim. Biophys.
Acta 1813, 238–259.
www.frontiersin.org June 2012 | Volume 2 | Article 59 | 15Clapp et al. Anti-apoptosis in humanized yeast
Pourova,J.,Kottova,M.,Voprsalova,M.,
and Pour, M. (2010). Reactive oxy-
gen and nitrogen species in normal
physiologicalprocesses.ActaPhysiol.
(Oxf) 198, 15–35.
Priault, M., Camougrand, N., Kinnally,
K. W., Vallette, F. M., and Manon,
S. (2003). Yeast as a tool to study
Bax/mitochondrial interactions in
cell death. FEMS Yeast Res. 4, 15–27.
Qi, H., Han, Y., and Rong, J. (2012).
Potential roles of PI3K/Akt and
Nrf2-Keap1 pathways in regulating
hormesis of Z-ligustilide in PC12
cells against oxygen and glucose
deprivation. Neuropharmacology 62,
1659–1670.
Qian, J., Ren, X., Wang, X., Zhang,
P., Jones, W. K., Molkentin, J.
D., Fan, G. C., and Kranias, E.
G. (2009). Blockade of Hsp20
phosphorylation exacerbates car-
diac ischemia/reperfusion injury
by suppressed autophagy and
increased cell death. Circ. Res. 105,
1223–1231.
Rami, A. (2009). Review: autophagy
in neurodegeneration: ﬁreﬁghter
and/or incendiarist? Neuropathol.
Appl. Neurobiol. 35, 449–461.
Rami, A., Bechmann, I., and Stehle,
J. H. (2008). Exploiting endoge-
nous anti-apoptotic proteins for
novel therapeutic strategies in cere-
bral ischemia. Prog. Neurobiol. 85,
273–296.
Ray, P. D., Huang, B. W., and Tsuji,
Y. (2012). Reactive oxygen species
(ROS) homeostasis and redox reg-
ulation in cellular signaling. Cell.
Signal. 24, 981–990.
Renault, T. T., Grandier-Vazeille,
X., Arokium, H., Velours, G.,
Camougrand, N., Priault, M., Tei-
jido, O., Dejean, L. M., and Manon,
S. (2011). The cytosolic domain of
human Tom22 modulates human
Bax mitochondrial translocation
and conformation in yeast. FEBS
Lett. 586, 116–121.
Ring, G., Khoury, C. M., Solar, A. J.,
Yang,Z.,Mandato,C.A.,andGreen-
wood, M. T. (2008). Transmem-
brane protein 85 from both human
(TMEM85) and yeast (YGL231c)
inhibit hydrogen peroxide mediated
cell death in yeast. FEBS Lett. 582,
2637–2642.
Ring, J., Sommer, C., Carmona-
Gutierrez, D., Ruckenstuhl, C.,
Eisenberg, T., and Madeo, F. (2012).
The metabolism beyond pro-
grammed cell death in yeast. Exp.
Cell Res. 318, 1193–1200.
Ristow, M., and Schmeisser, S. (2011).
Extending life span by increasing
oxidative stress. Free Radic. Biol.
Med. 51, 327–336.
Ristow, M., and Zarse, K. (2011). How
increased oxidative stress promotes
longevity and metabolic health: the
concept of mitochondrial hormesis
(mitohormesis). Exp. Gerontol. 45,
410–418.
Ritch, J. J., Davidson, S. M., Sheehan,
J. J., and Austriaco, N. (2010). The
Saccharomyces SUN gene, UTH1,
is involved in cell wall biogenesis.
FEMS Yeast Res. 10, 168–176.
Rockenfeller, P., and Madeo, F. (2010).
Ageingandeating.Biochim.Biophys.
Acta 1803, 499–506.
Rodrigues, V., Cordeiro-da-Silva, A.,
Laforge,M.,Ouaissi,A.,Silvestre,R.,
andEstaquier,J.(2012).Modulation
of mammalian apoptotic pathways
by intracellular protozoan parasites.
Cell. Microbiol. 14, 325–333.
Sakamoto, S., and Kyprianou, N.
(2010). Targeting anoikis resistance
in prostate cancer metastasis. Mol.
Aspects Med. 31, 205–214.
Sampaio-Marques, B., Felgueiras,
C., Silva, A., Rodrigues, F., and
Ludovico, P. (2011). Yeast chrono-
logical lifespan and proteotoxic
stress: is autophagy good or bad?
Biochem. Soc. Trans. 39, 1466–1470.
Sato, M., Cismowski, M. J., Toyota,
E., Smrcka, A. V., Lucchesi, P. A.,
Chilian, W. M., and Lanier, S. M.
(2006). Identiﬁcation of a receptor-
independent activator of G pro-
tein signaling (AGS8) in ischemic
heart and its interaction with Gbe-
tagamma. Proc. Natl. Acad. Sci.
U.S.A. 103, 797–802.
Schleicher, S. M., Moretti, L., Varki,
V., and Lu, B. (2010). Progress in
the unraveling of the endoplasmic
reticulum stress/autophagy pathway
and cancer: implications for future
therapeutic approaches. Drug Resist.
Updat. 13, 79–86.
Schonthal, A. H. (2009). Endo-
plasmic reticulum stress and
autophagy as targets for can-
cer therapy. Cancer Lett. 275,
163–169.
Separovic, D., Hanada, K., Maitah, M.
Y., Nagy, B., Hang, I., Tainsky, M.
A., Kraniak, J. M., and Bielawski,
J. (2007). Sphingomyelin synthase
1 suppresses ceramide production
and apoptosis post-photodamage.
Biochem. Biophys. Res. Commun.
358, 196–202.
Separovic, D., Semaan, L., Tarca, A.
L., Awad Maitah, M. Y., Hanada,
K., Bielawski, J., Villani, M., and
Luberto, C. (2008). Suppression of
sphingomyelin synthase 1 by small
interference RNA is associated with
enhanced ceramide production and
apoptosis after photodamage. Exp.
Cell Res. 314, 1860–1868.
Shamas-Din,A.,Brahmbhatt,H.,Leber,
B.,andAndrews,D.W.(2011).BH3-
onlyproteins:orchestratorsofapop-
tosis. Biochim. Biophys. Acta 1813,
508–520.
Sharon, A., Finkelstein, A., Shlezinger,
N., and Hatam, I. (2009). Fungal
apoptosis: function, genes and gene
function. FEMS Microbiol. Rev. 33,
833–854.
Shemarova, I. V. (2010). Signaling
mechanisms of apoptosis-like pro-
grammed cell death in unicellular
eukaryotes. Comp. Biochem. Physiol.
B Biochem. Mol. Biol. 155, 341–353.
Shen, H. M., and Codogno, P. (2012).
A u t o p h a g yi sas u r v i v a lf o r c ev i a
suppression of necrotic cell death.
Exp. Cell Res. Available at: http://dx.
doi.org/10.1016/j.yexcr.2012.02.006
Shen, S., Kepp, O., and Kroemer, G.
(2012). The end of autophagic cell
death? Autophagy 8, 10–3.
Shimizu, S., Kanaseki, T., Mizushima,
N., Mizuta, T., Arakawa-Kobayashi,
S., Thompson, C. B., and Tsuji-
moto, Y. (2004). Role of Bcl-2 fam-
ily proteins in a non-apoptotic pro-
grammed cell death dependent on
autophagy genes. Nat. Cell Biol. 6,
1221–1228.
Shlezinger, N., Minz, A., Gur, Y.,
Hatam, I., Dagdas, Y. F., Talbot,
N. J., and Sharon, A. (2011). Anti-
apoptotic machinery protects the
necrotrophic fungus Botrytis cinerea
from host-induced apoptotic-like
cell death during plant infec-
tion. PLoS Pathog. 7, e1002185.
doi:10.1371/journal.ppat.1002185
Silva, R. D., Manon, S., Goncalves,
J., Saraiva, L., and Corte-Real, M.
(2011a).Theimportanceof human-
ized yeast to better understand the
role of bcl-2 family in apopto-
sis: ﬁnding of novel therapeutic
opportunities. Curr. Pharm. Des. 17,
246–255.
Silva, R. D., Manon, S., Goncalves,
J., Saraiva, L., and Corte-Real, M.
(2011b). Modulation of Bax mito-
chondrial insertion and induced cell
death in yeast by mammalian pro-
tein kinase C alpha. Exp. Cell Res.
317, 781–790.
Strasser, A., Cory, S., and Adams, J. M.
(2011).Decipheringtherulesofpro-
grammedcelldeathtoimprovether-
apy of cancer and other diseases.
EMBO J. 30, 3667–3683.
Tao,W.,Kurschner,C.,andMorgan,J.I.
(1997). Modulation of cell death in
yeast by the Bcl-2 family of proteins.
J. Biol. Chem. 272, 15547–15552.
Tarnavski, O., McMullen, J. R., Schinke,
M., Nie, Q., Kong, S., and Izumo,
S. (2004). Mouse cardiac surgery:
comprehensive techniques for the
generation of mouse models of
human diseases and their applica-
tion for genomic studies. Physiol.
Genomics 16, 349–360.
Taylor, E. B., and Rutter, J. (2011).
Mitochondrial quality control by
the ubiquitin-proteasome system.
Biochem. Soc. Trans. 39, 1509–1513.
Teng, X., Cheng,W. C., Qi, B.,Yu, T. X.,
Ramachandran, K., Boersma, M. D.,
Hattier,T.,Lehmann,P.V.,Pineda,F.
J.,andHardwick,J.M.(2011).Gene-
dependent cell death in yeast. Cell
Death Dis. 2, e188.
Thevissen, K., Yen, W. L., Carmona-
Gutierrez, D., Idkowiak-Baldys, J.,
Aerts, A. M., Francois, I. E., Madeo,
F., Klionsky, D. J., Hannun, Y. A.,
andCammue,B.P.(2010).Skn1and
Ipt1 negatively regulate autophagy
in Saccharomyces cerevisiae. FEMS
Microbiol. Lett. 303, 163–168.
Ulukaya, E., Acilan, C., and Yilmaz,
Y. (2011). Apoptosis: why and how
does it occur in biology? Cell
Biochem. Funct. 29, 468–480.
Vaux, D. L., Cory, S., and Adams, J.
M. (1988). Bcl-2 gene promotes
haemopoieticcellsurvivalandcoop-
erates with c-myc to immortalize
pre-B cells. Nature 335, 440–442.
Vertessy,B.G.,andToth,J.(2009).Keep-
ing uracil out of DNA: physiological
role, structure and catalytic mecha-
nism of dUTPases. Acc. Chem. Res.
42, 97–106.
Walter, D., Wissing, S., Madeo, F.,
and Fahrenkrog, B. (2006). The
inhibitor-of-apoptosisproteinBir1p
protects against apoptosis in S. cere-
visiae and is a substrate for the yeast
homologue of Omi/HtrA2. J. Cell.
Sci. 119, 1843–1851.
Wang, C., Skinner, C., Easlon, E., and
Lin, S. J. (2009). Deleting the 14-3-
3 protein Bmh1 extends life span in
Saccharomyces cerevisiae by increas-
ing stress response. Genetics 183,
1373–1384.
Weinlich,R.,Dillon,C.P.,andGreen,D.
R. (2011). Ripped to death. Trends
Cell Biol. 21, 630–637.
Whelan, R. S., Kaplinskiy,V., and Kitsis,
R.N.(2010).Celldeathinthepatho-
genesisof heartdisease:mechanisms
and signiﬁcance. Annu. Rev. Physiol.
72, 19–44.
Wilkinson, S., and Ryan, K. M. (2010).
Autophagy:anadaptablemodiﬁerof
tumourigenesis. Curr. Opin. Genet.
Dev. 20, 57–64.
Williams, D., Norman, G., Khoury, C.,
Metcalfe, N., Briard, J., Laporte, A.,
Sheibani, S., Portt, L., Mandato, C.
A., and Greenwood, M. T. (2011).
Evidence for a second messen-
ger function of dUTP during Bax
mediated apoptosis of yeast and
Frontiers in Oncology | Molecular and Cellular Oncology June 2012 | Volume 2 | Article 59 | 16Clapp et al. Anti-apoptosis in humanized yeast
mammalian cells. Biochim. Biophys.
Acta 1813, 315–321.
Wilson, P. M., Labonte, M. J., Lenz,
H. J., Mack, P. C., and Ladner,
R. D. (2012). Inhibition of dUT-
Pase induces synthetic lethality with
thymidylate synthase-targeted ther-
apies in non-small cell lung cancer.
Mol. Cancer Ther. 11, 616–628.
Winderickx, J., Delay, C., De Vos, A.,
Klinger,H.,Pellens,K.,Vanhelmont,
T., Van Leuven, F., and Zabrocki, P.
(2008). Protein folding diseases and
neurodegeneration: lessons learned
from yeast. Biochim. Biophys. Acta
1783, 1381–1395.
Wissing,S.,Ludovico,P.,Herker,E.,But-
tner, S., Engelhardt, S. M., Decker,
T., Link, A., Proksch, A., Rodrigues,
F., Corte-Real, M., Frohlich, K. U.,
Manns, J., Cande, C., Sigrist, S. J.,
Kroemer, G., and Madeo, F. (2004).
AnAIForthologueregulatesapopto-
sisinyeast.J.CellBiol.166,969–974.
Woo, I. S., Eun, S. Y., Jang, H. S.,
Kang, E. S., Kim, G. H., Kim, H.
J., Lee, J. H., Chang, K. C., Kim,
J. H., Han, C. W., and Seo, H.
G. (2009). Identiﬁcation of ADP-
ribosylation factor 4 as a suppressor
of N-(4-hydroxyphenyl)retinamide-
induced cell death. Cancer Lett. 276,
53–60.
Woo, I. S., Jang, H. S., Eun, S. Y.,
Kim, H. J., Ham, S. A., Lee, J. H.,
Chang, K. C., Kim, J. H., Han, C.
W., and Seo, H. G. (2008). Ran
suppresses paclitaxel-induced apop-
tosis in human glioblastoma cells.
Apoptosis 13, 1223–1231.
Woo, I. S., Jin, H., Kang, E. S., Kim,
H. J., Lee, J. H., Chang, K. C., Park,
J. Y., Choi, W. S., and Seo, H. G.
(2011). TMEM14A inhibits N-(4-
hydroxyphenyl)retinamide-induced
apoptosis through the stabiliza-
tion of mitochondrial membrane
potential. Cancer Lett. 309,190–198.
Wu, W., Chaudhuri, S., Brickley, D. R.,
Pang, D., Karrison, T., and Conzen,
S. D. (2004). Microarray analy-
sis reveals glucocorticoid-regulated
survival genes that are associated
with inhibition of apoptosis in
breastepithelialcells.CancerRes.64,
1757–1764.
Wu,W.,Liu,P.,andLi,J.(2012).Necrop-
tosis: an emerging form of pro-
grammedcelldeath.Crit.Rev.Oncol.
Hematol. 82, 249–259.
Wyllie,A. H. (2010).“Where,o death,is
thysting?”abriefreviewofapoptosis
biology. Mol. Neurobiol. 42, 4–9.
Yacoubian, T. A., and Standaert, D. G.
(2009). Targets for neuroprotection
in Parkinson’s disease. Biochim. Bio-
phys. Acta 1792, 676–687.
Yang, Z., Khoury, C., Jean-Baptiste, G.,
and Greenwood,M. T. (2006). Iden-
tiﬁcation of mouse sphingomyelin
synthase 1 as a suppressor of Bax-
mediated cell death in yeast. FEMS
Yeast Res. 6, 751–762.
Yenari, M. A., Liu, J., Zheng, Z., Vexler,
Z. S., Lee, J. E., and Giffard, R.
G. (2005). Antiapoptotic and anti-
inﬂammatory mechanisms of heat-
shock protein protection. Ann. N. Y.
Acad. Sci. 1053, 74–83.
Zdralevic, M., Guaragnella, N.,
Antonacci, L., Marra, E., and
Giannattasio, S. (2012). Yeast as
a tool to study signaling path-
ways in mitochondrial stress
response and cytoprotection.
ScientiﬁcWorldJournal 2012,912147.
Zhivotovsky,B.,andOrrenius,S.(2010).
Cell death mechanisms: cross-talk
androleindisease.Exp.CellRes.316,
1374–1383.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received:24April2012;accepted:24May
2012; published online: 13 June 2012.
Citation: Clapp C, Portt L, Khoury C,
Sheibani S,Eid R,Greenwood M,Vali H,
Mandato CAandGreenwood MT(2012)
Untangling the roles of anti-apoptosis in
regulating programmed cell death using
humanizedyeastcells.Front.Oncol.2:59.
doi: 10.3389/fonc.2012.00059
This article was submitted to Frontiers
in Molecular and Cellular Oncology, a
specialty of Frontiers in Oncology.
Copyright © 2012 Clapp, Portt, Khoury,
Sheibani, Eid, Greenwood, Vali,
Mandato and Greenwood. This is an
open-access article distributed under
the terms of the Creative Commons
Attribution Non Commercial License,
which permits non-commercial use,
distribution, and reproduction in other
forums, provided the original authors
and source are credited.
www.frontiersin.org June 2012 | Volume 2 | Article 59 | 17